101 results on '"Dantzer, E."'
Search Results
2. Indicazioni dei sostituti cutanei e degli alloinnesti
- Author
-
Dantzer, E.
- Published
- 2015
- Full Text
- View/download PDF
3. Indicaciones de los sustitutos cutáneos y de los aloinjertos
- Author
-
Dantzer, E.
- Published
- 2015
- Full Text
- View/download PDF
4. Acute and post burn reconstructive surgery of the female trunk with artificial dermis to facilitate healthy pregnancy
- Author
-
Campech G, Mazanovich M, and Dantzer E
- Subjects
Marketing ,Pharmacology ,Organizational Behavior and Human Resource Management ,medicine.medical_specialty ,Reconstructive surgery ,Pregnancy ,business.industry ,Strategy and Management ,Pharmaceutical Science ,medicine.disease ,Surgery ,medicine.anatomical_structure ,Dermis ,Drug Discovery ,medicine ,business ,Female trunk - Published
- 2020
- Full Text
- View/download PDF
5. Cytomegalovirus infection in severe burn patients monitoring by real-time polymerase chain reaction: A prospective study
- Author
-
Bordes, J., Maslin, J., Prunet, B., d’Aranda, E., Lacroix, G., Goutorbe, P., Dantzer, E., and Meaudre, E.
- Published
- 2011
- Full Text
- View/download PDF
6. Place des dermes équivalents en chirurgie réparatrice des séquelles de brûlures
- Author
-
Dantzer, E.
- Published
- 2011
- Full Text
- View/download PDF
7. Stratégie chirurgicale des brûlures du cou et de leurs séquelles
- Author
-
Pradier, J.-P., Duhamel, P., Brachet, M., Dantzer, E., Vourey, G., and Bey, E.
- Published
- 2011
- Full Text
- View/download PDF
8. Limb Rehabilitation in the Burned Patient
- Author
-
Greco, I., Landi, G., Dantzer, E., Echinard, C., Masellis, M., editor, and Gunn, S. W. A., editor
- Published
- 1995
- Full Text
- View/download PDF
9. A non-surgical device for faecal diversion in the management of perineal burns
- Author
-
Bordes, J., Goutorbe, P., Asencio, Y., Meaudre, E., and Dantzer, E.
- Published
- 2008
- Full Text
- View/download PDF
10. Dermes équivalents
- Author
-
Dantzer, E., primary
- Published
- 2010
- Full Text
- View/download PDF
11. Acute and post burn reconstructive surgery of the female trunk with artificial dermis to facilitate healthy pregnancy
- Author
-
Dantzer, E, primary, Campech, G, additional, and Mazanovich, M, additional
- Published
- 2020
- Full Text
- View/download PDF
12. Dermal regeneration template for deep hand burns: clinical utility for both early grafting and reconstructive surgery
- Author
-
Dantzer, E, Queruel, P, Salinier, L, Palmier, B, and Quinot, J.F
- Published
- 2003
- Full Text
- View/download PDF
13. Intégra ®, une nouvelle alternative chirurgicale pour le traitement des grands brûlés. Évaluation clinique en chirurgie aiguë et réparatrice : à propos de 39 cas
- Author
-
Dantzer, E, Queruel, P, Salinier, L, Palmier, B, and Quinot, J.F
- Published
- 2001
- Full Text
- View/download PDF
14. Intérêt des dermes équivalents dans la chirurgie des dermo-hypodermites bactériennes nécrosantes : sept observations
- Author
-
Abed, S., Dantzer, E., Souraud, J.-B., Brissy, S., Fournier, B., Boyé, T., Guennoc, B., and Morand, J.-J.
- Published
- 2014
- Full Text
- View/download PDF
15. Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- Author
-
Bonaca, MP, Bhatt, DL, Cohen, M, Steg, PG, Storey, RF, Jensen, EC, Magnani, G, Bansilal, S, Fish, MP, Im, K, Bengtsson, O, Ophuis, TO, Budaj, A, Theroux, P, Ruda, M, Hamm, C, Goto, S, Spinar, J, Nicolau, JC, Kiss, RG, Murphy, SA, Wiviott, SD, Held, P, Braunwald, E, Sabatine, MS, Morin, S, Dantzer, E, Acquilano, D, McGuire, RL, Gannon, JB, Gershman, E, Ahlbom, AM, Boberg, B, Abola, MT, Ardissino, D, Aylward, P, Corbalan, R, Dalby, A, Diaz, R, Hu, DY, Isaza, D, Kamensky, G, Kiss, R, Kontny, F, Lopez-Sendon, J, Medina, F, Montalescot, G, Nicolau, J, Paolasso, E, Parkhomenko, A, Van De Werf, F, Anderson, JL, White, HD, Verheugt, FWA, Pedersen, TR, DeMets, DL, Lowe, C, Arevalo, C, Awtry, E, Berger, C, Croce, K, Desai, A, Gelfand, E, Ho, C, Leeman, D, Link, M, Norden, A, Pande, A, Rost, N, Ruberg, F, Silverman, S, Singhal, A, Vita, J, Alvarisqueta, A, De Gennaro, N, Berli, M, Roude, AE, Di Gennaro, JA, Albisu, JF, Caccavo, A, Torres, M, Cuadrado, J, Bordoni, P, Cuello, J, Aviles, A, Glenny, A, Recoaro, R, Fernandez, R, Strada, BN, Fuentealba, V, Gallo, C, Duran, RG, Garcia, C, Hominal, M, Castoldi, M, Jure, H, Pacora, FF, Lorenzatti, A, Martinez, JM, Macin, S, Cocco, N, MacKinnon, I, Bagnato, MB, Marino, J, Cusimano, S, Arias, V, Focaccia, M, Muntaner, J, Mansilla, V, Poy, C, Prado, A, Paterlini, G, Montana, O, Camino, A, Sala, J, Luciani, C, Vico, M, Morell, Y, Dumont, C, Vottero, E, Zangroniz, P, Lescano, A, Morara, P, Marquez, LL, Patron, FR, Labarta, GB, Sivila, CD, Quiroga, AR, Maffei, L, Sassone, S, Rolandi, F, Vesentini, N, Carnero, G, Del Verme, S, Hershson, A, Figal, JC, Viso, ME, Hii, C, Smith, K, Singh, B, Acampo, M, Rogers, J, ODonoghue, M, Amerena, J, Long, A, Dart, A, Kay, S, Worthley, M, Nimmo, J, Lehman, R, Morrison, H, Dick, R, Savage, C, van Gaal, W, Park, M, Blombery, P, McCarthy, C, Oqueli, E, Hill, D, Sader, M, Vrachas, D, Purnell, P, Vibert, J, Collins, N, Gordon, A, Arstall, M, Rose, J, Aroney, C, Cleave, P, Fitzpatrick, M, Mackenzie, M, Garrahy, P, Hall, C, Nelson, G, Reid, E, Lee, A, Gibbs, J, Thompson, P, Crittenden, J, Hammett, C, Hindom, L, Antonis, P, Manzoney, A, Cross, D, Pollard, C, Brieger, D, Wu, J, Whelan, A, Tulloch, G, Taylor, A, Smith, B, Horowitz, J, Black, M, Boland, J, Malmendier, D, Celen, H, Wendelen, E, Claeys, M, Pieter, M, Cools, F, Simons, N, De Maeseneire, S, De Wolf, L, Brike, C, Dubois, P, Bolado, ACY, Foading-Deffo, B, Tahon, S, Friart, A, Arend, C, Gevaert, S, Verdegem, P, Marechal, P, Gits, F, Pierard, L, Celentano, C, Pirenne, B, Bouvy, C, Renkin, J, Huyberechts, D, Sinnaeve, P, De Velder, L, Stammen, F, Casier, T, Striekwold, H, Van den Broeck, D, Thoeng, J, Goris, R, Timmermans, P, Collard, SJ, Van De Borne, P, De Clippel, M, Wollaert, B, Jacobs, C, Vankelecom, B, Daelemans, Y, Vervoort, G, Drieghe, S, Vranckx, P, Janssen, A, Vrolix, M, Simenon, I, Wijns, W, Delacroix, H, Denie, D, Schoors, D, Lemoine, I, Cornelis, K, Willems, AM, Schroder, E, Domange, J, Greque, G, Machado, H, Armaganijan, D, Del Monaco, MI, da Silva, D, Nakazone, R, Dutra, O, Vaz, R, Daher, R, Rodrigues, D, Guimaraes, A, Teixeira, A, Saraiva, J, Leaes, P, Blacher, M, Maia, L, Nakazone, MA, Manenti, E, Ruschel, K, Marin-Neto, J, Pavao, R, Preto, R, Junior, AA, Oliveira, G, Rassi, S, Sampaio, D, Rossi, PR, dos Santos, L, de Souza, J, Lino, E, Filho, PP, Zucchetti, C, Gomes, M, de Paiva, A, Sousa, AC, Almeida, A, Botelho, R, da Silva, R, Giraldez, R, Franken, M, Faludi, A, Bertolami, M, Hernandes, M, Lucas, N, Carvalho, A, Bertolami, A, Precoma, D, Geralde, L, Pereira, A, Cesar, L, Mioto, B, Marino, R, Rabelo, W, dos Santos, F, Vidotti, M, Mangione, J, Mauro, M, Kormann, A, Ultramari, F, Zimmermann, S, Michalaros, Y, Fonseca, M, Sampaio, C, Eliaschewitz, F, Barbosa, E, Drews, C, de Lorenzo, A, Barros, C, Cancado, G, Neuesnchwander, F, Zimmermann, E, Chompalova, B, Denchev, S, Gocheva, N, Mihov, A, Mincheva, V, Gelev, V, Tisheva, S, Todorov, G, Goudev, A, Parvanova, Z, Todorova, M, Mitkova, M, Smilov, L, Yakovova, S, Milanova, K, Aleksov, N, Mollov, M, Shishmanova, D, Hristova, K, Uzunangelov, Y, Peltegov, V, Karamitev, G, Benov, H, Vasileva, D, Parishev, G, Milcheva, N, Avramov, D, Miteva, B, Stoyanovski, V, Pencheva, G, Nikolova, L, Stancheva, N, Nyagina, M, Markov, D, Spirova, D, Peneva, Y, Peshkov, O, Mitkova, L, Mandzhukova, S, Rangelova, V, Ivanov, K, Krusheva, B, Raycheva, V, Gergova, V, Goranov, K, Stoykov, A, Staleva, M, Rashkova, V, Postadzhian, A, Krancheva, V, Lulova, E, Delchev, G, Cantor, W, Constance, C, Gosselin, G, Marr, D, Pandey, A, Pesant, Y, Pouliot, J, Gladstone, P, McPherson, T, Rupka, D, Saw, J, St-Amour, E, Syan, G, Syan, R, Rosenbloom, A, Vizel, S, Della Siega, A, Halperin, F, Nigro, F, Chehayeb, R, Fell, D, Labonte, R, Nawaz, S, Gupta, M, Ma, P, Glanz, A, Kouz, S, Bhargava, R, Dion, D, Dupuis, R, Grondin, F, Wong, B, Sabbah, E, Hui, W, Belisle, P, Tymchak, W, Montigny, M, Lonn, E, Bose, S, Kincade, D, Gallo, R, Lamy, A, Bell, A, Lemay, M, Bata, I, Kostuk, W, Cheung, S, Petrella, R, Lubelsky, B, Berlingieri, J, Fortin, C, DeYoung, J, Babapulle, M, Landry, D, Gupta, A, Bertrand, O, Jadin, M, Robbins, K, Gauthier, MF, Masson, C, Reyes, V, O'Blenis, G, Clarus, S, Sardin, V, Marquette, S, Bozek, B, Spurrell, D, Thiessen, S, Fox, R, Tremblay, I, Singh, J, Samms, S, Ross, B, Solomon, P, Nelson, S, Roberts, P, Forsyth, C, Lepage, C, McPherson, C, Dewar, C, Dela Cruz, C, Louch, D, Vilag, C, Roy, M, Stata, C, Morissette, A, Ouimet, F, Bilodeau, N, Chausse, I, Kvill, L, Chartrand, MJ, Harris, L, Bolduc, H, Magi, A, Jule, P, Valley, S, Morrissette, J, Power, P, Kailey, P, Thomas, A, Wright, D, Carr, S, Cleveland, T, Dihel, C, Coldwell, J, Schellenberg, S, Viau, C, Watt, M, Corke, R, Shea-Landry, G, Gandhi, A, Tishler, S, Prieto, JC, Noriega, V, Cobos, L, Obreque, C, Potthof, S, Zapata, J, Lucero, F, Luque, M, Pincetti, C, Torres, G, Yanez, M, Vasquez, C, Manriquez, L, Espinoza, MJ, Yovaniniz, P, Grandon, M, Castro, P, Llevaneras, S, Lanas, F, Hidalgo, J, Arriagada, G, Villan, C, Florenzano, F, Chacon, MV, Rodriguez, M, Barreda, B, Raffo, C, Reyes, T, Hu, D, Liu, W, Tan, N, Feng, Y, Dong, Y, Yang, D, Liao, Y, Wei, F, Wei, M, Yan, M, Yan, X, Wang, S, Li, Y, Yuan, Z, Xiong, Y, Zhu, J, Li, S, Ma, G, Chen, L, Li, Z, Liu, Y, Xiong, W, Pang, W, Chen, Y, Lu, G, Chen, Z, Zhao, S, Zhou, H, Huang, J, Gang, Y, Chai, Y, Yang, X, Zhang, Z, Mu, Z, Hernandez, E, Mora, C, Maria, E, Catalan, Y, Reynales, H, Huertas, D, Molina, D, Rendon, N, Sanchez, G, Tellez, R, Botero, R, Salazar, P, Vesga, B, Delgado, P, Herrera, M, Perez, D, Jaramillo, N, Toloza, R, Orozco, A, Bustamante, Y, Jaramillo, C, Garces, G, Saaibi, J, Castillo, J, Arana, C, Gonzalez, M, Urina, M, Ramirez, N, Manzur, F, Rosales, D, Quintero, A, Gonzalez, E, Accini, J, Reyes, M, Elbl, L, Malecha, J, Stanek, L, Jerabek, O, Lubanda, H, Kos, P, Zidkova, E, Vlckova, D, Naplava, R, Ludka, O, Ludkova, A, Soucek, M, Kuchar, J, Poloczek, M, Wasserburger, B, Panovsky, R, Linhart, A, Rihacek, I, Macha, J, Grunfeldova, H, Spinarova, L, Zanova, M, Bren, J, Zarembova, J, Cermak, O, Sembera, Z, Svobodova, I, Monhart, Z, Pleva, L, Sipula, J, Polasek, R, Kolmas, P, Dedek, V, Janota, T, Stipal, R, Kucera, D, Bednarova, J, Broulova, P, Lukac, M, Hanak, P, Reichert, P, Bouchal, P, Turkova, N, Krocova, E, Petrova, I, Matyasek, I, Brychta, T, Machova, V, Marusincova, I, Sperlingova, B, Macquin-Mavier, T, Khalife, K, Galley, D, Elhadad, S, Decoulx, E, Cottin, Y, Coisne, D, Bonnet, JL, Ferrari, E, Range, G, Cayla, G, Goralski, M, Furber, A, Elbaz, M, Aboyans, V, Poulard, JE, Zemour, G, Labeque, JN, Hirsch, JL, Vaquette, B, Livarek, B, Igigabel, P, Lafitte, S, Oudghiri, M, Bertin, B, Beitar, T, Merkling, D, Beltra, C, Maubert, A, El Jarroudi, M, Bichat, F, Berger, N, Fiacchetti, C, Douillet, M, Laure, C, Leperchois-Jacquey, C, Miran, S, Cornet, C, Rosolin, N, Pradel, V, Leparree, S, Doux, N, Mais, C, Sevilla, J, Laurencon, V, Georges, J, Gilard, V, Duprat, C, Giannitsis, E, Schenkenberger, I, Appel, KF, Toursarkissian, N, Bott, J, Nischik, R, Schmidt, E, Jung, T, Steiner, S, Khariouzov, A, Heuer, H, Kadel, C, Hanefeld, M, Weil, J, Koenig, W, Horacek, T, Muenzel, T, Brachmann, J, Weber, D, Wittlich, N, Stellbrink, C, Dungen, HD, Leschke, M, Zeymer, U, Dorsel, T, Voehringer, HF, Dissmann, M, Vom Dahl, J, Derwahl, KM, Trenk, D, Frey, N, Schroeder, T, Foerster, A, Bartels, R, Kisselbach, C, Deigentasch, H, Dreykluft, K, Becker, P, Scheuren, A, Erdas, M, Wipper, J, Schmidt, A, Henzler, A, Winter, K, Fischer, S, Kopf, S, Laschewski, B, Rahn, G, Schrapel, C, Miodek, M, Hildenbrand, S, Fink, P, Gebel, G, Goebel, U, Siepmann, C, Drexler, A, Maiwald, A, Blaich, B, Baumann, S, Iselt, M, Gebhardt, S, Kazcmarek, N, Krug-Hoeren, B, Traubler, B, Nicula, D, Reichenbach, D, Langer, C, Kiroglu, K, Riedel, S, Schulte, M, Borst, M, Katona, A, Vertes, A, Merkely, B, Ungi, I, Kiraly, C, Zolyomi, S, Horvath, I, Lupkovics, G, Edes, I, Simon, E, Czuriga, I, Laszlo, Z, Kancz, S, Takacs, J, Papp, A, Czigany, A, Muller, G, Tas, AS, Polgar, P, Jilling, MJ, Bartal, G, Kerkovits, A, Bodi, M, Benczur, B, Valco, J, Erdei, F, Sebo, J, Korda, A, Turi, T, Becker, D, Kalapos, A, Bosko, M, Pap, G, Magyari, B, Basa, A, Jenei, C, Bakai, J, Unterberger, K, Vas, K, Fulop, G, Nagy, M, Takacs, A, Mate, Z, Szilagyi, A, Nagy, K, Svab, M, Kis, E, Horthy, R, Kantor, F, Sperr, E, Bajcsi, E, Bujdoso, A, Martina, P, Fiscella, A, Marenzi, G, Tamburino, C, Terrosu, P, Presbitero, P, Cuccia, C, Bovenzi, F, Berti, S, Colivicchi, F, Paloscia, L, Scherillo, M, Tartaglione, S, Della Rovere, F, De Cesare, N, Manari, A, Astarita, C, Oltrona, L, Marzilli, M, Caldarola, P, Merlini, P, Celentano, A, Di Sciascio, G, Pajes, G, Silvestri, O, Delfino, R, Bassani, F, Cavallini, C, Fattore, L, Di Lorenzo, L, Notarangelo, F, Stefanin, C, Giacoppo, M, Rubino, M, Dammino, L, Chessa, P, Di Pizzo, A, Musmeci, G, Mazzoni, A, Tyack, K, Aiello, A, Mascellanti, M, Formigli, D, Guglielmino, G, Bernabo, P, Bocciarelli, M, De Iaco, G, Russo, G, Rizzotti, D, Orsini, E, Saponetti, LS, Babbolin, M, De Divitiis, M, Patti, G, Monti, F, Silvestri, N, Valbusa, A, Lazzarotti, M, Puccetti, L, Grikstaite, E, Patrizi, G, Bosco, B, Marchegiano, R, Takenaka, T, Ono, M, Suzuki, M, Hasegawa, K, Domae, H, Fukui, K, Iseki, H, Aoyama, T, Suzuki, C, Sakai, R, Hashimoto, T, Inoko, M, Sasaki, T, Kataoka, T, Okutsu, M, Yasaka, Y, Miyamoto, T, Tomobuchi, Y, Tamura, R, Hosokawa, S, Komura, Y, Takahashi, N, Mima, T, Sadamatsu, K, Fujimoto, K, Matsumura, T, Koide, S, Himi, T, Hashimoto, Y, Yamasaki, M, Okubo, M, Takase, H, Morii, I, Utsu, N, Higashino, Y, Shigematsu, S, Nakagawa, T, Ota, T, Takahashi, W, Kakishita, M, Hayashi, Y, Momiyama, Y, Baden, M, Saeki, T, Hiroi, S, Wada, A, Nakata, A, Nishi, Y, Hirasawa, S, Shibata, Y, Fukuzawa, S, Machida, M, Takama, N, Teranishi, J, Sakuma, K, Abe, Y, Suzuki, A, Yamazaki, A, Nakachi, T, Nagayama, H, Fujino, S, Tsurukai, A, Nojima, S, Ishiguchi, Y, Hada, K, Nakatani, K, Yamamoto, K, Matsuo, A, Yamaguchi, E, Ito, S, Matsuda, M, Onishi, M, Kawanishi, Y, Ohashi, Y, Ochi, K, Miyamoto, S, Ichishita, Y, Iwamoto, H, Sagara, Y, Komori, M, Matsumura, A, Nakashima, R, Kondo, M, Suzuki, K, Kodama, S, Kotajima, H, Fujimoto, N, Honda, K, Iwamoto, M, Okada, S, Ichinose, K, Takinami, N, Takagi, E, Nakano, A, Tomari, H, Yokoyama, T, Matsui, Y, Nishimura, N, Asano, T, Mochiduki, A, Yamashita, S, Okino, S, Hirabayashi, K, Funada, R, Wardeh, AJ, Dille, C, De Melker, EC, van der Spoel, A, Willems, FF, Maassen, E, Westendorp, ICD, Zweers, D, Dunselman, PHJM, Blom, L, Ronner, E, Wissenburg, A, van der Sluis, A, Badings, EA, den Hartog, FR, Singerling, M, Aksoy, I, Heil, A, Tjeerdsma, G, van Daalen, C, Lenderink, T, Lardenois, R, Prins, FJ, Rutten, R, Plomp, J, Veldmeijer, S, De Vries, RJM, Krikken, J, Ophuis, TAJMO, Buvelot, S, Bos, RJ, Tan-Urgert, B, Werner, HA, Wittekoek, M, van Daele, MERM, Bouwens, M, Oomen, A, Meijlis, P, Verheul, JA, Uiterwaal, H, Knufman, N, de Lange, H, Bartels, GL, Hendriks-Van Woerden, M, van Bemmel, B, Beyering, M, Zwart, PAG, Teng, Y, van der Zwaan, C, Havenaar, J, Hermans, WRM, de Graauw, J, Hamraoui, K, Dabrowska, K, de Nooijer, C, Groenenberg, I, Kietselae, BLJH, Muis, L, Hamer, BJB, Hobe, C, van Eck, JWM, Elzebroek, N, Tans, JGM, Stapel, AGT, Nierop, PR, Dirks, M, Kuijper, AFM, Schiks, M, de Groot, MR, Post, G, ten Berg, JM, Bras, R, Koolen, JJ, van Leur, L, Herrman, JPR, Roelse, A, Ebink, C, Jones, B, Lipsic, E, Couperus, M, Bogaard, K, Dijk, A, Pettersen, KI, Fortun, M, Gullestad, L, Stueflotten, W, Popovic, I, Sobye, ET, Hogalmen, G, German, M, Hysing, J, Flagstad, E, Slettom, G, Nordrehaug, JE, Isaksen, A, Graven, T, Haug, H, Sandvik, J, Thunhaug, H, Ronning, PB, Gravrok, B, Lappegard, KT, Enebakk, T, Ronnevik, P, Ronnevik, T, Hurtig, U, Skanke, E, Omland, T, Tobiassen, GM, Berrospi, P, Ragas, Y, Bustamante, G, Marruffo, Y, Chavez, E, Chaname, A, Heredia, J, Gamero, K, Lema, J, Carrion, AM, Rodriguez, V, Cabanillas, N, Rodriguez, A, Zena, N, Segura, L, Rojas, C, Toce, L, Carrera, J, Orihuela, B, Del Portal, M, Roldan, Y, Roldan, G, Rodriguez, J, Chavez, C, Luna, G, Parra, J, Ramos, J, Mogrovejo, W, Godoy, J, Talledo, MZ, Diestra, J, Godoy, A, Matta, M, Pino, C, Vergara, R, Chois, A, Guillen, AM, Medina, J, Chirinos, J, Paredes, A, Quiroz, M, Camacho, L, Gil, M, Cerbito, S, Beltran, J, Tanglao, M, Uy, N, Busa, J, Rogelio, G, Arbis, MG, Prado, JP, Miranda, M, Sulit, DJ, Dioquino, R, Sevilla, R, Soriano, RA, Rosita, RR, Amazona, A, Atilano, A, Lim, E, Ebo, G, Maglasang, P, Palmes, P, Loreno, CA, Tirador, L, Alagban, C, Roxas, DJ, Roxas, JF, Cheng, F, De Guzman, S, Morales, D, Mararac, T, Barbas, B, Barbas, K, Ferrolino, A, Baysac, C, Llarena, AC, Julianes, C, Torun, A, Dalkowski, M, Widejko, K, Derlaga, B, Laskowska, E, Dudek, D, Dziewierz, A, Jozwa, R, Busz-Papiez, B, Pawlowicz, L, Kaczmarczyk, M, Jaworska, K, Skonieczny, G, Kopaczewski, J, Wujkowski, M, Krasowski, W, Krzyzanek, P, Kubica, J, Kozinski, M, Miekus, P, Glaza, M, Podolec, P, Wilkolek, P, Piepiorka, M, Piepiorka-Broniecka, M, Pluta, W, Ploch, M, Rynkiewicz, A, Mosakowska, K, Szpajer, M, Lesinski, D, Szwed, H, Jasek, S, Sciborski, R, Piotrowicz, R, Musial, W, Lisowska, A, Rekosz, J, Kasznicka, M, Korzeniak, R, Staneta, P, Konczakowski, P, Waluszek-Konczakowska, I, Cymerman, K, Lubinski, A, Grycewicz, T, Hiczkiewicz, J, Plucinski, M, Korol, M, Szczech, J, Hawro, M, Skorski, M, Cichon, K, Jankowski, M, Cygler, J, Ottomanska-Cygler, M, Korecki, J, Gulaj, E, Zechowicz, T, Zechowicz, M, Goch, A, Topolinski, B, Ogorek, M, Szczepanska, A, Wojewoda, P, Jagoda, E, Krzyzanowski, W, Muzyk-Osikowicz, M, Jaszczurowski, W, Stasiewski, A, Wietrzynska, J, Miklaszewicz, B, Beme, A, Sudnik, W, Matys, U, Ponikowski, P, Powierza, S, Kim, YH, Choi, DJ, Seung, KB, Lim, DS, Lee, SH, Kim, HS, Bae, JH, Hong, TJ, Hong, MK, Tahk, SJ, Kim, YJ, Yoon, J, Jeong, MH, Chae, JK, Cho, MC, Hong, SK, Hur, SH, Jeong, JO, Her, SH, Lee, JM, Chang, KC, Yoon, CH, Chang, K, Park, J, Choi, S, Park, K, Bae, Y, Lee, H, Kim, BK, Yoon, MH, Park, JS, Jang, H, Kim, C, Cho, EJ, Bae, J, Lee, D, Lee, J, Choi, YY, Dimulescu, D, Vintila, M, Fruntelata, A, Pirvu, O, Stanciulescu, G, Giuca, A, Militaru, C, Radoi, M, Bobescu, E, Crisu, D, Creteanu, M, Minescu, B, Bolohan, F, Manitiu, I, Bengus, C, Iosipescu, L, Ciobotaru, V, Basarab, G, Benedek, I, Constantinescu, M, Cristea, M, Capalneanu, R, Tatu-Chitoiu, G, Huidu, S, Protopopescu, L, Greavu, M, Diaconu, M, Blajan, D, Istratoaie, O, Lican, G, Bisoc, A, Doka, B, Jemna, D, Parasteac, M, Serban, L, Mihai, M, Cioca, G, Ochean, V, Costache, L, Andor, M, Stoica, D, Benedek, T, Sava, N, Anciu, M, Mot, S, Cornaciu, S, Boldueva, S, Golitsyn, S, Karpov, Y, Kobalava, Z, Konstantinov, V, Kuimov, A, Ezhov, M, Panov, A, Novikova, T, Simanenkov, V, Smolenskaya, O, Tsyba, L, Vishnevsky, A, Yakhontova, P, Kislyak, O, Demchenko, E, Yakovlev, A, Ermoshkina, L, Arkhipov, M, Galyavich, A, Strongin, L, Kosmacheva, E, Goloshchekin, B, Sidorenko, B, Izmozherova, N, Shustov, S, Orlikova, O, Lukyanov, Y, Koziolova, N, Nedogoda, S, Statsenko, M, Kotelnikov, M, Osipenko, M, Oshchepkova, E, Bolieva, L, Ryamzina, I, Pavlysh, E, Samokhvalova, M, Mironova, N, Buza, V, Shavarov, A, Serebrenitskaya, M, Khomyakova, L, Safarova, M, Lohovinina, N, Staroverov, I, Bitakova, F, Zakharova, N, Khurs, E, Belenky, D, Kositsyn, D, Rovnykh, Y, Kasatova, T, Lubinskaya, E, Omelchenko, M, Slukhaenko, I, Kozulin, A, Baleeva, L, Pochinka, I, Kizhvatova, N, Laptev, I, Bugrimova, M, Popov, A, Kovalevskaya, E, Orlikov, E, Paltsman, Z, Lamden, D, Surovtseva, M, Tsoma, V, Derevjanchenko, M, Streltsov, S, Bikbulatova, E, Dmitriev, V, Byazrova, S, Khovaeva, Y, Komandenko, O, Dlesk, A, Urban, M, Vinanska, D, Dzupina, A, Hranai, M, Cisar, P, Toth, P, Paulov, S, Sivak, V, Bolvanska, N, Pella, D, Palka, J, Nedelova, I, Benacka, J, Gergel, V, Hatalova, K, Kohut, P, Kovar, F, Knazeje, M, Macek, V, Sinska, R, Bugan, V, Badenhorst, JCW, Erasmus, L, Burgess, LJ, de Necker, I, Corbett, CH, Fouche, L, Dawood, SY, Conradie, C, Delport, EF, Kruger, M, Ebrahim, I, Bobak, C, Nethononda, MR, Nunkoo, T, van Rensburg, FPJ, Middle, R, Horak, AR, Henley, L, Mabin, TA, King, A, Ranjith, N, Ramdas, S, Roodt, A, Coetsee, E, Theron, H, Karsten, M, Van Zyl, LJ, Roscher, M, Venter, TP, de Kock, L, Becker, AC, Swanepoel, J, Ismail, SM, Dalby, AJ, Allman, J, Roux, JP, Christie, H, Naidoo, DP, Vawda, GHM, Manga, P, Olckers, W, Mpe, MT, Farrell, BM, Areses, ELD, Lopez, SV, Fernandez, JMC, Roldan, JG, Pavia, PG, Segovia, AG, Puig, JG, Garcia, VC, Aguilera, RM, Munoa, MD, Cortada, JB, Cereto, PC, Perez, IP, Cid, LP, Basilio, EG, Guerra, PC, Ortiz, AF, Balcones, LDV, Vera, TR, Martinez, JMG, Galvan, ED, Caballero, AH, Blanco, VMR, Lopez, JMR, Franco, MRP, Soriano, FR, Porcar, LC, Fillat, ARC, Moreno, SG, Montejano, MG, Guerrero, JMD, Coronado, JLB, Eizagaechevarria, NM, Araucua, GN, Rubio, AM, Roca, MC, Marimon, XGM, Perales, MV, Gonzalez, AB, Sastre, MP, Juanatey, JRG, Acuna, JMG, Al-Khalili, F, Lof, P, Bandh, S, Myllyla, L, Christensen, K, Johansson, K, Dellborg, M, Hultsberg-Olsson, G, Alstrom, P, Damm, TL, Erlinge, D, Brolin, G, Ravn-Fischer, PA, Johansson, P, Andreen, S, Linderfalk, C, Ram, B, Lindholm, CJ, Assarsson, E, Mooe, T, Lindberg, A, Paren, P, Moodh, J, Svensson, P, Andersson, I, Wodlin, P, Raschperger, A, Skogvard, P, Koch, A, Lind, N, Osberg, L, Nilsson, C, Svensson, K, Bengtsson, M, Samad, B, Nilsson, M, Berglund, E, Lundgren, C, Lindmark, K, Sundholm, C, Aladellie, L, Welin-Berger, B, Guneri, S, Dogan, NB, Ersanli, M, Coskun, U, Cayli, M, Seker, T, Camsari, A, Ozcan, T, Ongen, Z, Karadag, B, Boyaci, B, Sezenoz, B, Pekdemir, H, Hidayet, S, Erol, M, Yalcin, A, Sezer, M, Emet, S, Bozkurt, E, Ozen, MB, Lutay, Y, Dyadyk, O, Kholopov, L, Rudyk, I, Shaposhnikova, Y, Chopey, I, Ternuschak, T, Reshotko, D, Popova, G, Batushkin, V, Gema, A, Vizir, V, Berezyn, O, Lutai, M, Tovstukha, V, Shumakov, V, Pogurelska, O, Sirenko, Y, Rekovets, O, Kraiz, I, Kamenska, E, Tseluyko, V, Yakovleva, L, Yena, L, Artemenko, V, Koval, O, Kaplan, P, Karpenko, O, Nevolina, I, Bazilevych, A, Harbar, M, Rudenko, L, Beregova, O, Mostovyi, Y, Rasputina, L, Vatutin, M, Shevelok, A, Kovalenko, V, Polenova, N, Amosova, K, Tkachenko, L, Volkov, V, Zaprovalna, O, Storey, R, Thomas, M, Pell, A, Moriarty, A, Kinnin, M, Ahsan, A, Burton, J, ORourke, B, Young, J, Lang, C, Forbes, J, Rowlands, D, Hamill, S, Sprigings, D, Cadd, A, de Belder, M, Atkinson, B, Ramsey, M, Fagan, JC, Pye, M, Wright, L, Keeling, P, Hughes, D, Fraser, D, Phillips, H, Muthusamy, R, Lawan, M, Levy, T, Kennard, S, Bodalia, B, Mottram, J, Calvert, J, Brodie, K, Gunstone, A, Douglas, C, Trouton, T, Hunter, B, Gerber, R, Pepper, H, Mathur, A, Andiapen, M, Baumbach, A, Bowles, R, Hildick-Smith, D, McGregor, A, Loh, I, Plocky, J, Adams, K, Clemmer, K, Aggarwal, K, Burkhardt, V, Costa, M, Lemmertz, K, Anderson, J, York, T, Angiolillo, D, Green, E, Sperling, M, Vasquez, E, Aycock, G, Tatum, D, Amin, J, Davidson, A, Hendrix, E, Shepard, L, Strain, J, Michel, K, Talano, J, Szalanski, N, Berk, M, Ibarra, M, Bhagwat, R, Winterrowd, D, Bilazarian, S, Marsters, M, Blonder, R, Graf, L, Brilakis, E, Roesle, M, Byrd, L, Sullivan, A, Longo, J, Pennella, A, Westerhausen, D, Weil, R, Carr, K, Piazza, J, Carr, KW, Castello, R, Hawks, M, Chandna, H, Holly, D, Chandrashekhar, YS, Molinaro, N, Carter, M, Antonino, M, Kosmicki, D, Kelley, M, Richwine, R, Pazier, P, Glasgow, B, Bresee, S, Alexander, J, Concha, M, Martinez, E, Connelly, T, Schenks, R, Cooper, M, Garman, V, Condit, J, White, A, Fialkow, J, Mckercher, M, Luna, M, Soto, G, Prodafikas, J, Rambaud, B, Donovan, J, Mudd, D, Doty, W, Parsons, T, D'Urso, M, Bies, J, Han, J, Treadwell, M, Erickson, B, Dahl, P, Fattal, P, Braem, J, Felten, W, Prior, J, French, W, Barillas, O, Berger, R, Genova, E, Gelernt, M, Cockrell, D, Miller, G, Dumka, K, Gill, S, Elliot, S, Goldberg, R, Barrett, M, Gordon, P, Stern, L, Ayres, T, Rhule, V, Gupta, D, Holton, T, Haddad, T, Jain, J, Hakas, J, McSorley, J, Hamroff, G, Hollenweger, L, Wainwright, W, Jones, S, Casagrande, M, Casagrande, MG, Effat, M, Mardis, R, Henderson, D, Millard, D, Hermany, P, Meissner-Dengler, S, Hinchman, D, Luck, K, Hodson, R, Severson, L, Horwitz, P, Miller, K, Isserman, S, Moore, C, Jan, M, Bilyk, O, Kersh, R, DaCosta, A, Kim, E, Gonzales, C, Kmetzo, J, Taylor, D, Knutson, T, Belanger, B, Hage-Korban, E, Harrington, A, Murdock, D, Heiman, M, Dandekar, U, Khan, M, Khan, G, Lui, H, Holman, L, MacDonald, L, Derbyshire, S, Watkins, K, Mayer, N, Mitchell, B, McCullum, K, Delio-Cox, B, Mckay, R, Cloutier, J, McKenzie, M, Rodkey, K, McLaurin, B, Lack, A, Minisi, A, Jeter, D, Mitchell, R, Keane-Richmond, P, Stine, R, Bullivant, M, Morford, R, White, J, Oberoi, M, Geraldo-Abache, A, O'Dea, D, Mehta, R, Tang, N, Ong, S, Edwards, M, Osborne, J, Alonzo, C, Lev, V, Monroe, J, Popeil, L, Sorrentino, N, Portelli, J, Landi, T, Potu, R, Smith, N, Prashad, R, McDonough, C, Qureshi, M, Howe, A, Raikhel, M, Arsate, M, Rogers, W, Saag, L, Sangrigoli, R, Schwarz, L, Abu-Fadel, M, Hagee, A, Kinnaman, S, McDaniel, V, Wilson, V, Purcell, T, Roberts, J, Riofrio, K, Shah, U, Narang, S, Gredler, F, Knap, P, Shanes, J, Hansen, C, Sharma, M, Gibson, T, Sheldon, W, Bohn, A, Siegel, C, Tibbits, L, Singh, V, Nelson, M, Singh, N, Logwood, D, Randhawa, P, Vargas, B, Stegemoller, R, Cole, B, Aggarwal, R, Johnson, M, Steinhoff, J, Dunaway, B, Patel, K, Boomer, L, Taheri, H, Morgan, K, Tahirkheli, N, Santos, A, Thadani, U, Alexander, D, Bennett, W, Kelley, E, Thomas, J, Macnicholas, D, Varma, S, Evans, S, Vlastaris, A, Bittel, B, Voyce, S, Mack, B, Weiss, R, Fournier, T, Whitney, R, Orosco, C, Willis, J, VonGerichten, S, Wiseman, A, Sharrow, A, Wohns, D, Schuitema, J, Amin, M, Ramus, A, Wilson, W, Moeller, C, Newell, M, Tindell, L, Rivera, W, Kwierant, J, Bretton, E, Corbin, B, Labroo, A, Lopez, C, Brown, C, Craig, M, Lucca, M, Keinanen, T, Eisenberg, S, Fielding, M, Doorey, A, Squire, A, Suresh, D, Frost, J, Teklinski, A, Stone, B, Waksman, R, Griffin, S, Wharton, W, Blakely, J, Fishbein, G, Weller, C, Camp, A, Fisher, S, Meholick, A, Hejna, E, Anderson, R, Long, S, Parikh, S, Norton, N, Vijay, N, Washam, M, Smith, S, and Stepanov, N
- Abstract
BACKGROUND The potential benefit of dual antiplatelet therapy beyond 1 year after a myocardial infarction has not been established. We investigated the efficacy and safety of ticagrelor, a P2Y(12) receptor antagonist with established efficacy after an acute coronary syndrome, in this context. METHODS We randomly assigned, in a double-blind 1: 1: 1 fashion, 21,162 patients who had had a myocardial infarction 1 to 3 years earlier to ticagrelor at a dose of 90 mg twice daily, ticagrelor at a dose of 60 mg twice daily, or placebo. All the patients were to receive low-dose aspirin and were followed for a median of 33 months. The primary efficacy end point was the composite of cardiovascular death, myocardial infarction, or stroke. The primary safety end point was Thrombolysis in Myocardial Infarction (TIMI) major bleeding. RESULTS The two ticagrelor doses each reduced, as compared with placebo, the rate of the primary efficacy end point, with Kaplan-Meier rates at 3 years of 7.85% in the group that received 90 mg of ticagrelor twice daily, 7.77% in the group that received 60 mg of ticagrelor twice daily, and 9.04% in the placebo group (hazard ratio for 90 mg of ticagrelor vs. placebo, 0.85; 95% confidence interval [CI], 0.75 to 0.96; P = 0.008; hazard ratio for 60 mg of ticagrelor vs. placebo, 0.84; 95% CI, 0.74 to 0.95; P = 0.004). Rates of TIMI major bleeding were higher with ticagrelor (2.60% with 90 mg and 2.30% with 60 mg) than with placebo (1.06%) (P < 0.001 for each dose vs. placebo); the rates of intracranial hemorrhage or fatal bleeding in the three groups were 0.63%, 0.71%, and 0.60%, respectively. CONCLUSIONS In patients with a myocardial infarction more than 1 year previously, treatment with ticagrelor significantly reduced the risk of cardiovascular death, myocardial infarction, or stroke and increased the risk of major bleeding. (Funded by AstraZeneca; PEGASUS-TIMI 54 ClinicalTrials.gov number, NCT01225562.)
- Published
- 2015
16. A shortened verbal autopsy instrument for use in routine mortality surveillance systems
- Author
-
Serina, P, Riley, I, Stewart, A, Flaxman, AD, Lozano, R, Mooney, MD, Luning, R, Hernandez, B, Black, R, Ahuja, R, Alam, N, Alam, SS, Ali, SM, Atkinson, C, Baqui, AH, Chowdhury, HR, Dandona, L, Dandona, R, Dantzer, E, Darmstadt, GL, Das, V, Dhingra, U, Dutta, A, Fawzi, W, Freeman, M, Gamage, S, Gomez, S, Hensman, D, James, SL, Joshi, R, Kalter, HD, Kumar, A, Kumar, V, Lucero, M, Mehta, S, Neal, B, Ohno, SL, Phillips, D, Pierce, K, Prasad, R, Praveen, D, Premji, Z, Ramirez-Villalobos, D, Rampatige, R, Remolador, H, Romero, M, Said, M, Sanvictores, D, Sazawal, S, Streatfield, PK, Tallo, V, Vadhatpour, A, Wijesekara, N, Murray, CJL, Lopez, AD, Serina, P, Riley, I, Stewart, A, Flaxman, AD, Lozano, R, Mooney, MD, Luning, R, Hernandez, B, Black, R, Ahuja, R, Alam, N, Alam, SS, Ali, SM, Atkinson, C, Baqui, AH, Chowdhury, HR, Dandona, L, Dandona, R, Dantzer, E, Darmstadt, GL, Das, V, Dhingra, U, Dutta, A, Fawzi, W, Freeman, M, Gamage, S, Gomez, S, Hensman, D, James, SL, Joshi, R, Kalter, HD, Kumar, A, Kumar, V, Lucero, M, Mehta, S, Neal, B, Ohno, SL, Phillips, D, Pierce, K, Prasad, R, Praveen, D, Premji, Z, Ramirez-Villalobos, D, Rampatige, R, Remolador, H, Romero, M, Said, M, Sanvictores, D, Sazawal, S, Streatfield, PK, Tallo, V, Vadhatpour, A, Wijesekara, N, Murray, CJL, and Lopez, AD
- Abstract
BACKGROUND: Verbal autopsy (VA) is recognized as the only feasible alternative to comprehensive medical certification of deaths in settings with no or unreliable vital registration systems. However, a barrier to its use by national registration systems has been the amount of time and cost needed for data collection. Therefore, a short VA instrument (VAI) is needed. In this paper we describe a shortened version of the VAI developed for the Population Health Metrics Research Consortium (PHMRC) Gold Standard Verbal Autopsy Validation Study using a systematic approach. METHODS: We used data from the PHMRC validation study. Using the Tariff 2.0 method, we first established a rank order of individual questions in the PHMRC VAI according to their importance in predicting causes of death. Second, we reduced the size of the instrument by dropping questions in reverse order of their importance. We assessed the predictive performance of the instrument as questions were removed at the individual level by calculating chance-corrected concordance and at the population level with cause-specific mortality fraction (CSMF) accuracy. Finally, the optimum size of the shortened instrument was determined using a first derivative analysis of the decline in performance as the size of the VA instrument decreased for adults, children, and neonates. RESULTS: The full PHMRC VAI had 183, 127, and 149 questions for adult, child, and neonatal deaths, respectively. The shortened instrument developed had 109, 69, and 67 questions, respectively, representing a decrease in the total number of questions of 40-55%. The shortened instrument, with text, showed non-significant declines in CSMF accuracy from the full instrument with text of 0.4%, 0.0%, and 0.6% for the adult, child, and neonatal modules, respectively. CONCLUSIONS: We developed a shortened VAI using a systematic approach, and assessed its performance when administered using hand-held electronic tablets and analyzed using Tariff 2.0. The len
- Published
- 2015
17. Improving performance of the Tariff Method for assigning causes of death to verbal autopsies
- Author
-
Serina, P, Riley, I, Stewart, A, James, SL, Flaxman, AD, Lozano, R, Hernandez, B, Mooney, MD, Luning, R, Black, R, Ahuja, R, Alam, N, Alam, SS, Ali, SM, Atkinson, C, Baqui, AH, Chowdhury, HR, Dandona, L, Dandona, R, Dantzer, E, Darmstadt, GL, Das, V, Dhingra, U, Dutta, A, Fawzi, W, Freeman, M, Gomez, S, Gouda, HN, Joshi, R, Kalter, HD, Kumar, A, Kumar, V, Lucero, M, Maraga, S, Mehta, S, Neal, B, Ohno, SL, Phillips, D, Pierce, K, Prasad, R, Praveen, D, Premji, Z, Ramirez-Villalobos, D, Rarau, P, Remolador, H, Romero, M, Said, M, Sanvictores, D, Sazawal, S, Streatfield, PK, Tallo, V, Vadhatpour, A, Vano, M, Murray, CJL, Lopez, AD, Serina, P, Riley, I, Stewart, A, James, SL, Flaxman, AD, Lozano, R, Hernandez, B, Mooney, MD, Luning, R, Black, R, Ahuja, R, Alam, N, Alam, SS, Ali, SM, Atkinson, C, Baqui, AH, Chowdhury, HR, Dandona, L, Dandona, R, Dantzer, E, Darmstadt, GL, Das, V, Dhingra, U, Dutta, A, Fawzi, W, Freeman, M, Gomez, S, Gouda, HN, Joshi, R, Kalter, HD, Kumar, A, Kumar, V, Lucero, M, Maraga, S, Mehta, S, Neal, B, Ohno, SL, Phillips, D, Pierce, K, Prasad, R, Praveen, D, Premji, Z, Ramirez-Villalobos, D, Rarau, P, Remolador, H, Romero, M, Said, M, Sanvictores, D, Sazawal, S, Streatfield, PK, Tallo, V, Vadhatpour, A, Vano, M, Murray, CJL, and Lopez, AD
- Abstract
BACKGROUND: Reliable data on the distribution of causes of death (COD) in a population are fundamental to good public health practice. In the absence of comprehensive medical certification of deaths, the only feasible way to collect essential mortality data is verbal autopsy (VA). The Tariff Method was developed by the Population Health Metrics Research Consortium (PHMRC) to ascertain COD from VA information. Given its potential for improving information about COD, there is interest in refining the method. We describe the further development of the Tariff Method. METHODS: This study uses data from the PHMRC and the National Health and Medical Research Council (NHMRC) of Australia studies. Gold standard clinical diagnostic criteria for hospital deaths were specified for a target cause list. VAs were collected from families using the PHMRC verbal autopsy instrument including health care experience (HCE). The original Tariff Method (Tariff 1.0) was trained using the validated PHMRC database for which VAs had been collected for deaths with hospital records fulfilling the gold standard criteria (validated VAs). In this study, the performance of Tariff 1.0 was tested using VAs from household surveys (community VAs) collected for the PHMRC and NHMRC studies. We then corrected the model to account for the previous observed biases of the model, and Tariff 2.0 was developed. The performance of Tariff 2.0 was measured at individual and population levels using the validated PHMRC database. RESULTS: For median chance-corrected concordance (CCC) and mean cause-specific mortality fraction (CSMF) accuracy, and for each of three modules with and without HCE, Tariff 2.0 performs significantly better than the Tariff 1.0, especially in children and neonates. Improvement in CSMF accuracy with HCE was 2.5%, 7.4%, and 14.9% for adults, children, and neonates, respectively, and for median CCC with HCE it was 6.0%, 13.5%, and 21.2%, respectively. Similar levels of improvement are seen in an
- Published
- 2015
18. Nécrose du gland après injection volontaire de buprénorphine dans un contexte de toxicomanie aux opioïdes
- Author
-
Hornez, E., Laroche, J., Monchal, T., Bourgouin, S., Riviere, P., Fournier, R., and Dantzer, E.
- Published
- 2010
- Full Text
- View/download PDF
19. Using verbal autopsy to measure causes of death: the comparative performance of existing methods
- Author
-
Murray, CJL, Lozano, R, Flaxman, AD, Serina, P, Phillips, D, Stewart, A, James, SL, Vahdatpour, A, Atkinson, C, Freeman, MK, Ohno, SL, Black, R, Ali, SM, Baqui, AH, Dandona, L, Dantzer, E, Darmstadt, GL, Das, V, Dhingra, U, Dutta, A, Fawzi, W, Gomez, S, Hernandez, B, Joshi, R, Kalter, HD, Kumar, A, Kumar, V, Lucero, M, Mehta, S, Neal, B, Praveen, D, Premji, Z, Ramirez-Villalobos, D, Remolador, H, Riley, I, Romero, M, Said, M, Sanvictores, D, Sazawal, S, Tallo, V, Lopez, AD, Murray, CJL, Lozano, R, Flaxman, AD, Serina, P, Phillips, D, Stewart, A, James, SL, Vahdatpour, A, Atkinson, C, Freeman, MK, Ohno, SL, Black, R, Ali, SM, Baqui, AH, Dandona, L, Dantzer, E, Darmstadt, GL, Das, V, Dhingra, U, Dutta, A, Fawzi, W, Gomez, S, Hernandez, B, Joshi, R, Kalter, HD, Kumar, A, Kumar, V, Lucero, M, Mehta, S, Neal, B, Praveen, D, Premji, Z, Ramirez-Villalobos, D, Remolador, H, Riley, I, Romero, M, Said, M, Sanvictores, D, Sazawal, S, Tallo, V, and Lopez, AD
- Abstract
BACKGROUND: Monitoring progress with disease and injury reduction in many populations will require widespread use of verbal autopsy (VA). Multiple methods have been developed for assigning cause of death from a VA but their application is restricted by uncertainty about their reliability. METHODS: We investigated the validity of five automated VA methods for assigning cause of death: InterVA-4, Random Forest (RF), Simplified Symptom Pattern (SSP), Tariff method (Tariff), and King-Lu (KL), in addition to physician review of VA forms (PCVA), based on 12,535 cases from diverse populations for which the true cause of death had been reliably established. For adults, children, neonates and stillbirths, performance was assessed separately for individuals using sensitivity, specificity, Kappa, and chance-corrected concordance (CCC) and for populations using cause specific mortality fraction (CSMF) accuracy, with and without additional diagnostic information from prior contact with health services. A total of 500 train-test splits were used to ensure that results are robust to variation in the underlying cause of death distribution. RESULTS: Three automated diagnostic methods, Tariff, SSP, and RF, but not InterVA-4, performed better than physician review in all age groups, study sites, and for the majority of causes of death studied. For adults, CSMF accuracy ranged from 0.764 to 0.770, compared with 0.680 for PCVA and 0.625 for InterVA; CCC varied from 49.2% to 54.1%, compared with 42.2% for PCVA, and 23.8% for InterVA. For children, CSMF accuracy was 0.783 for Tariff, 0.678 for PCVA, and 0.520 for InterVA; CCC was 52.5% for Tariff, 44.5% for PCVA, and 30.3% for InterVA. For neonates, CSMF accuracy was 0.817 for Tariff, 0.719 for PCVA, and 0.629 for InterVA; CCC varied from 47.3% to 50.3% for the three automated methods, 29.3% for PCVA, and 19.4% for InterVA. The method with the highest sensitivity for a specific cause varied by cause. CONCLUSIONS: Physician review of verba
- Published
- 2014
20. Infection à cytomégalovirus chez le patient brûlé grave
- Author
-
Bordes, J., primary, Hraiech, S., additional, Lehingue, S., additional, Nguyen, C., additional, Dantzer, E., additional, and Meaudre, E., additional
- Published
- 2014
- Full Text
- View/download PDF
21. Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets
- Author
-
Murray, CJL, Lopez, AD, Black, R, Ahuja, R, Ali, SM, Baqui, A, Dandona, L, Dantzer, E, Das, V, Dhingra, U, Dutta, A, Fawzi, W, Flaxman, AD, Gomez, S, Hernandez, B, Joshi, R, Kalter, H, Kumar, A, Kumar, V, Lozano, R, Lucero, M, Mehta, S, Neal, B, Ohno, SL, Prasad, R, Praveen, D, Premji, Z, Ramirez-Villalobos, D, Remolador, H, Riley, I, Romero, M, Said, M, Sanvictores, D, Sazawal, S, Tallo, V, Murray, CJL, Lopez, AD, Black, R, Ahuja, R, Ali, SM, Baqui, A, Dandona, L, Dantzer, E, Das, V, Dhingra, U, Dutta, A, Fawzi, W, Flaxman, AD, Gomez, S, Hernandez, B, Joshi, R, Kalter, H, Kumar, A, Kumar, V, Lozano, R, Lucero, M, Mehta, S, Neal, B, Ohno, SL, Prasad, R, Praveen, D, Premji, Z, Ramirez-Villalobos, D, Remolador, H, Riley, I, Romero, M, Said, M, Sanvictores, D, Sazawal, S, and Tallo, V
- Abstract
BACKGROUND: Verbal autopsy methods are critically important for evaluating the leading causes of death in populations without adequate vital registration systems. With a myriad of analytical and data collection approaches, it is essential to create a high quality validation dataset from different populations to evaluate comparative method performance and make recommendations for future verbal autopsy implementation. This study was undertaken to compile a set of strictly defined gold standard deaths for which verbal autopsies were collected to validate the accuracy of different methods of verbal autopsy cause of death assignment. METHODS: Data collection was implemented in six sites in four countries: Andhra Pradesh, India; Bohol, Philippines; Dar es Salaam, Tanzania; Mexico City, Mexico; Pemba Island, Tanzania; and Uttar Pradesh, India. The Population Health Metrics Research Consortium (PHMRC) developed stringent diagnostic criteria including laboratory, pathology, and medical imaging findings to identify gold standard deaths in health facilities as well as an enhanced verbal autopsy instrument based on World Health Organization (WHO) standards. A cause list was constructed based on the WHO Global Burden of Disease estimates of the leading causes of death, potential to identify unique signs and symptoms, and the likely existence of sufficient medical technology to ascertain gold standard cases. Blinded verbal autopsies were collected on all gold standard deaths. RESULTS: Over 12,000 verbal autopsies on deaths with gold standard diagnoses were collected (7,836 adults, 2,075 children, 1,629 neonates, and 1,002 stillbirths). Difficulties in finding sufficient cases to meet gold standard criteria as well as problems with misclassification for certain causes meant that the target list of causes for analysis was reduced to 34 for adults, 21 for children, and 10 for neonates, excluding stillbirths. To ensure strict independence for the validation of methods and assessment
- Published
- 2011
22. Intérêt des dermes équivalents dans les dermo-hypodermites bactériennes nécrosantes : sept observations
- Author
-
Abed, S., primary, Dantzer, E., additional, Souraud, J.-B., additional, Brissy, S., additional, Fournier, B., additional, Boyé, T., additional, Guennoc, B., additional, and Morand, J.-J., additional
- Published
- 2012
- Full Text
- View/download PDF
23. A one-step surgical grafting procedure for deep burns closure with tridimentional dermal matrix
- Author
-
Dantzer, E., primary, Pradier, J., additional, Chesnier, Y., additional, Meaudre, E., additional, Boret, H., additional, and Goutorbe, P., additional
- Published
- 2009
- Full Text
- View/download PDF
24. Endovascular warming of severe burned patients to maintain normothermia during surgery: A prospective study
- Author
-
Prunet, B., primary, Lacroix, G., additional, D’aranda, E., additional, Maurin, O., additional, Dantzer, E., additional, and Goutorbe, P., additional
- Published
- 2009
- Full Text
- View/download PDF
25. Burn Contractures: Surgical Management With Integra—Long Term Results
- Author
-
Dantzer, E., primary
- Published
- 2003
- Full Text
- View/download PDF
26. Intégra®, une nouvelle alternative chirurgicale pour le traitement des grands brûlés. Évaluation clinique en chirurgie aiguë et réparatrice : à propos de 39 cas
- Author
-
Dantzer, E, primary, Queruel, P, additional, Salinier, L, additional, Palmier, B, additional, and Quinot, J.F, additional
- Published
- 2001
- Full Text
- View/download PDF
27. Reconstructive surgery using an artificial dermis (Integra): results with 39 grafts
- Author
-
Dantzer, E. and Braye, F.M.
- Abstract
Integra was initially developed for the primary coverage of acute burns. It acts as a network for dermal reconstruction. An epidermal graft overlay is necessary after 3 weeks to achieve the in vivo reconstruction of a full-thickness skin equivalent. The quality of the functional and aesthetic results achieved led us to evaluate the potential of Integra in the treatment of burn scars and for general reconstructive surgery. We present a series of 31 patients who underwent Integra grafting for reconstructive surgery at a total of 39 operational sites. The average area grafted per procedure was 267 cm^2. Complications (silicone detachment, failure of the graft, haematoma) were observed in nine cases. The length of follow-up ranged from 0.5 year to 4 years. Two patients (two sites) were lost to follow-up; the final results in the remaining patients were considered to be good in 28 cases, average in six cases and poor in three cases. The disadvantages of using Integra in reconstructive surgery are the necessity of two operations, the risks of infection under the silicone layer, of the silicone becoming detached and of recurrence of contraction. On the other hand, Integra has many advantages including its immediate availability, the availability of large quantities, the simplicity and reliability of the technique, and the pliability and the cosmetic appearance of the resulting cover. In the light of these preliminary results, Integra appears as a new alternative to full-thickness skin grafting, skin expansion and even skin flaps for reconstructive surgery.
- Published
- 2001
- Full Text
- View/download PDF
28. [Development of non-cellular dermis: a step towards a total artificial skin]
- Author
-
Echinard, C., Dantzer, E., Poinsignon, F., Damour, O., Vescovali, C., David, Mf, Marchetti, B., Adhoute, H., Sahabeddin, L., Collombel, C., and Deleage, Gilbert
- Subjects
[SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology - Abstract
In large cutaneous defects due to severe burns, dermal mesenchyme healing has to be controlled in order to avoid granulation tissue that rapidly leads to important contractures and hypertrophic scars. We report a study about the use of an artificial dermis made of human collagen (I and III) and several glycosaminoglycans. This artificial dermis was grafted on Sprague-Dawley rats after a 9 cm2 skin excision on the back. An identical control area was made just under it, on the same animal. The animals were killed on day 2, 7, 14, 21, 30 and different parameters were studied: clinical study, bacteriological study, histopathological appearance, scanning and transmission electron microscopy, immunological study, physical parameters, UV absorption. Direct and indirect cytotoxicity tests, performed on cell cultures showed no change in the morphology and of the growth of the keratinocytes or of the fibroblasts. A biocompatibility study showed on the early days (day 2, 7, 14) that adherence of artificial dermis to the underlying tissue was good. There was virtually no bacterial colonization. Ultrastructural study showed an important cellular colonization, with an inflammatory appearance at the beginning. After a while, fibroblasts appeared, with synthesis of neocollagen fibers as early as the second week. Histological study showed neovessels in the artificial dermis. Later (day 21, 30) the inflammation was less severe and the amount of endogenous collagen increased.(ABSTRACT TRUNCATED AT 250 WORDS)In large cutaneous defects due to severe burns, dermal mesenchyme healing has to be controlled in order to avoid granulation tissue that rapidly leads to important contractures and hypertrophic scars. We report a study about the use of an artificial dermis made of human collagen (I and III) and several glycosaminoglycans. This artificial dermis was grafted on Sprague-Dawley rats after a 9 cm2 skin excision on the back. An identical control area was made just under it, on the same animal. The animals were killed on day 2, 7, 14, 21, 30 and different parameters were studied: clinical study, bacteriological study, histopathological appearance, scanning and transmission electron microscopy, immunological study, physical parameters, UV absorption. Direct and indirect cytotoxicity tests, performed on cell cultures showed no change in the morphology and of the growth of the keratinocytes or of the fibroblasts. A biocompatibility study showed on the early days (day 2, 7, 14) that adherence of artificial dermis to the underlying tissue was good. There was virtually no bacterial colonization. Ultrastructural study showed an important cellular colonization, with an inflammatory appearance at the beginning. After a while, fibroblasts appeared, with synthesis of neocollagen fibers as early as the second week. Histological study showed neovessels in the artificial dermis. Later (day 21, 30) the inflammation was less severe and the amount of endogenous collagen increased.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1989
29. Chapitre 21 - Dermes équivalents
- Author
-
Dantzer, E.
- Full Text
- View/download PDF
30. Maintenance of normothermia during burn surgery with an intravascular temperature control system: A non-randomised controlled trial.
- Author
-
Prunet B, Asencio Y, Lacroix G, Bordes J, Montcriol A, D'Aranda E, Pradier JP, Dantzer E, Meaudre E, Goutorbe P, and Kaiser E
- Published
- 2012
31. Forest-Going as a Risk Factor for Confirmed Malaria in Champasak Province, Lao PDR: A Case-Control Study.
- Author
-
Gallalee S, Dantzer E, Rerolle F, Chindavongsa K, Phongluxa K, Lasichanh W, Smith JL, Gosling R, Lover A, Hongvanthong B, and Bennett A
- Subjects
- Laos epidemiology, Case-Control Studies, Humans, Risk Factors, Male, Female, Adult, Middle Aged, Adolescent, Young Adult, Child, Travel statistics & numerical data, Child, Preschool, Infant, Aged, Malaria epidemiology, Forests
- Abstract
Lao People's Democratic Republic (Lao PDR) has made significant progress in reducing malaria in recent years. In the Greater Mekong Subregion, forest-going is often a risk factor contributing to continuing malaria transmission. This study assessed forest-going and other potential risk factors for malaria cases in Champasak Province, Lao PDR. Routine passive surveillance data from August 2017 to December 2018 were extracted from health facilities in three districts for a case-control study; at the time of presentation, all fever cases were asked to report any recent forest travel. Multivariable logistic regression was used to assess the relationship between forest-going and malaria infection while controlling for other covariates. Of 2933 fever cases with data available on forest-sleeping and malaria diagnosis from 25 health facilities, 244 (8%) tested positive (cases), and 2689 (92%) tested negative (controls). Compared with spending 0-2 nights in the forest, spending 3-7 nights in the forest was associated with 9.7 times the odds of having a malaria infection (95% CI: 4.67-20.31, p < 0.001) when adjusting for gender, occupation, and season. Forest-going, especially longer trips, is associated with increased risk for confirmed symptomatic malaria in southern Lao PDR, and appropriate and targeted intervention efforts are needed to protect this high-risk population.
- Published
- 2024
- Full Text
- View/download PDF
32. Genomic epidemiology demonstrates spatially clustered, local transmission of Plasmodium falciparum in forest-going populations in southern Lao PDR.
- Author
-
Chen YA, Vickers EN, Aranda-Diaz A, Murphy M, Gerlovina I, Rerolle F, Dantzer E, Hongvanthong B, Chang HH, Lover AA, Hathaway NJ, Bennett A, and Greenhouse B
- Subjects
- Laos epidemiology, Humans, Male, Female, Adult, Adolescent, Child, Middle Aged, Young Adult, Genomics methods, Child, Preschool, Plasmodium falciparum genetics, Malaria, Falciparum transmission, Malaria, Falciparum epidemiology, Malaria, Falciparum parasitology, Forests
- Abstract
While there has been significant progress in controlling falciparum malaria in the Lao People's Democratic Republic (PDR), sporadic cases persist in southern provinces where the extent and patterns of transmission remain largely unknown. To assess parasite transmission in this area, 53 Plasmodium falciparum (Pf) positive cases detected through active test and treat campaigns from December 2017 to November 2018 were sequenced, targeting 204 highly polymorphic amplicons. Two R packages, MOIRE and Dcifer, were applied to assess the multiplicity of infections (MOI), effective MOI (eMOI), within-host parasite relatedness, and between-host parasite relatedness ([Formula: see text]). Genomic data were integrated with survey data to characterize the temporal and spatial structures of identified clusters. The positive cases were mainly captured during the focal test and treat campaign conducted in 2018, and in the Pathoomphone area, which had the highest test positivity and forest activity. About 30% of the cases were polyclonal infections, with over half of theses (63%) showing within-host relatedness greater than 0.6, suggesting that cotransmission rather than superinfection was primarily responsible for maintaining polyclonality. A large majority of cases (81%) were infected by parasites genetically linked to one or more other cases. We identified five genetically distinct clusters in forest fringe villages within the Pathoomphone district, characterized by a high degree of genetic relatedness between parasites (mean [Formula: see text] = 0.8). Four smaller clusters of 2-3 cases linked Moonlapamok and Pathoomphone districts, with an average [Formula: see text] of 0.6, suggesting cross-district transmission. Most of the clustered cases occurred within 20 km and 2 months of each other, consistent with focal transmission. Transmission clusters identified in this study confirm the role of ongoing focal parasite transmission occurring within the forest or forest-fringe in the highly mobile population., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Chen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
33. Publisher Correction: Population size estimation of seasonal forest-going populations in southern Lao PDR.
- Author
-
Rerolle F, Jacobson JO, Wesson P, Dantzer E, Lover AA, Hongvanthong B, Smith J, Marshall JM, Sturrock HJW, and Bennett A
- Published
- 2023
- Full Text
- View/download PDF
34. Characterizing mobility patterns of forest goers in southern Lao PDR using GPS loggers.
- Author
-
Rerolle F, Dantzer E, Phimmakong T, Lover A, Hongvanthong B, Phetsouvanh R, Marshall J, Sturrock H, and Bennett A
- Subjects
- Child, Humans, Laos, Risk Factors, Forests, Malaria epidemiology
- Abstract
Background: In the Greater Mekong Subregion (GMS), forest-going populations are considered high-risk populations for malaria and are increasingly targeted by national control programmes' elimination efforts. A better understanding of forest-going populations' mobility patterns and risk associated with specific types of forest-going trips is necessary for countries in the GMS to achieve their objective of eliminating malaria by 2030., Methods: Between March and November 2018, as part of a focal test and treat intervention (FTAT), 2,904 forest-goers were recruited in southern Lao PDR. A subset of forest-goers carried an "i-Got-U" GPS logger for roughly 2 months, configured to collect GPS coordinates every 15 to 30 min. The utilization distribution (UD) surface around each GPS trajectory was used to extract trips to the forest and forest-fringes. Trips with shared mobility characteristics in terms of duration, timing and forest penetration were identified by a hierarchical clustering algorithm. Then, clusters of trips with increased exposure to dominant malaria vectors in the region were further classified as high-risk. Finally, gradient boosting trees were used to assess which of the forest-goers' socio-demographic and behavioural characteristics best predicted their likelihood to engage in such high-risk trips., Results: A total of 122 forest-goers accepted carrying a GPS logger resulting in the collection of 803 trips to the forest or forest-fringes. Six clusters of trips emerged, helping to classify 385 (48%) trips with increased exposure to malaria vectors based on high forest penetration and whether the trip happened overnight. Age, outdoor sleeping structures and number of children were the best predictors of forest-goers' probability of engaging in high-risk trips. The probability of engaging in high-risk trips was high (~ 33%) in all strata of the forest-going population., Conclusion: This study characterized the heterogeneity within the mobility patterns of forest-goers and attempted to further segment their role in malaria transmission in southern Lao People's Democratic Republic (PDR). National control programmes across the region can leverage these results to tailor their interventions and messaging to high-risk populations and accelerate malaria elimination., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
35. Characterizing the spatial distribution of multiple malaria diagnostic endpoints in a low-transmission setting in Lao PDR.
- Author
-
Byrne I, Cramer E, Nelli L, Rerolle F, Wu L, Patterson C, Rosado J, Dumont E, Tetteh KKA, Dantzer E, Hongvanthong B, Fornace KM, Stresman G, Lover A, Bennett A, and Drakeley C
- Abstract
The epidemiology of malaria changes as prevalence falls in low-transmission settings, with remaining infections becoming more difficult to detect and diagnose. At this stage active surveillance is critical to detect residual hotspots of transmission. However, diagnostic tools used in active surveillance generally only detect concurrent infections, and surveys may benefit from sensitive tools such as serological assays. Serology can be used to interrogate and characterize individuals' previous exposure to malaria over longer durations, providing information essential to the detection of remaining foci of infection. We ran blood samples collected from a 2016 population-based survey in the low-transmission setting of northern Lao PDR on a multiplexed bead assay to characterize historic and recent exposures to Plasmodium falciparum and vivax . Using geostatistical methods and remote-sensing data we assessed the environmental and spatial associations with exposure, and created predictive maps of exposure within the study sites. We additionally linked the active surveillance PCR and serology data with passively collected surveillance data from health facility records. We aimed to highlight the added information which can be gained from serology as a tool in active surveillance surveys in low-transmission settings, and to identify priority areas for national surveillance programmes where malaria risk is higher. We also discuss the issues faced when linking malaria data from multiple sources using multiple diagnostic endpoints., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Byrne, Cramer, Nelli, Rerolle, Wu, Patterson, Rosado, Dumont, Tetteh, Dantzer, Hongvanthong, Fornace, Stresman, Lover, Bennett and Drakeley.)
- Published
- 2022
- Full Text
- View/download PDF
36. Performance of five pulse oximeters to detect hypoxaemia as an indicator of severe illness in children under five by frontline health workers in low resource settings - A prospective, multicentre, single-blinded, trial in Cambodia, Ethiopia, South Sudan, and Uganda.
- Author
-
Baker K, Petzold M, Mucunguzi A, Wharton-Smith A, Dantzer E, Habte T, Matata L, Nanyumba D, Okwir M, Posada M, Sebsibe A, Nicholson J, Marasciulo M, Izadnegahdar R, Alfvén T, and Källander K
- Abstract
Background: Low blood oxygen saturation (SpO
2 ), or hypoxaemia, is an indicator of severe illness in children. Pulse oximetry is a globally accepted, non-invasive method to identify hypoxaemia, but rarely available outside higher-level facilities in resource-constrained countries. This study aims to evaluate the performance of different types of pulse oximeters amongst frontline health workers in Cambodia, Ethiopia, South Sudan, and Uganda., Methods: Five pulse oximeters (POx) which passed laboratory testing, out of an initial 32 potential pulse oximeters, were evaluated by frontline health workers for performance, defined as agreement between the SpO2 measurements of the test device and the reference standard. The study protocol is registered with the Australia New Zealand Clinical Trials Registry (Ref: ACTRrn12615000348550)., Findings: Two finger-tip pulse oximeters (Contec and Devon), two handheld pulse oximeters (Lifebox and Utech), and one phone pulse oximeter (Masimo) passed the laboratory testing. They were evaluated for performance on 1,313 children under five years old by 207 frontline health workers between February and May 2015. Phone and handheld pulse oximeters had greater overall agreement with the reference standard (56%; 95% CI 0.52 - 0.60 to 68%; 95% CI 0.65 - 0.71) than the finger-tip POx (31%; 95% CI 0.26 to 0.36 and 47%; 95% CI 0.42 to 0.52). Fingertip POx performance was substantially lower in the 0-2 month olds; having just 17% and 25% agreement. The finger-tip devices more often underreported SpO2 readings (mean difference -7.9%; 95%CI -8.6,-7.2 and -3.9%; 95%CI -4.4,-3.4), and therefore over diagnosed hypoxaemia in the children assessed., Interpretation: While the Masimo phone pulse oximeter performed best, all handheld POx with age-specific probes performed well in the hands of frontline health workers, further highlighting their suitability as a screening tool of severe illness. The poor performance of the fingertip POx suggests they should not be used in children under five by frontline health workers. It is essential that POx are performance tested on children in routine settings (in vivo), not only in laboratories or controlled settings (in vitro), before being introduced at scale., Funding: Bill & Melinda Gates Foundation [OPP1054367]., Competing Interests: All authors had full access to all the data in the study and accept responsibility to submit for publication. None of the authors has any conflict of interest to declare and all authors have completed the ICMJE form., (© 2021 The Author(s).)- Published
- 2021
- Full Text
- View/download PDF
37. Population size estimation of seasonal forest-going populations in southern Lao PDR.
- Author
-
Rerolle F, Jacobson JO, Wesson P, Dantzer E, Lover AA, Hongvanthong B, Smith J, Marshall JM, Sturrock HJW, and Bennett A
- Abstract
Forest-going populations are key to malaria transmission in the Greater Mekong Sub-region (GMS) and are therefore targeted for elimination efforts. Estimating the size of this population is essential for programs to assess, track and achieve their elimination goals. Leveraging data from three cross-sectional household surveys and one survey among forest-goers, the size of this high-risk population in a southern province of Lao PDR between December 2017 and November 2018 was estimated by two methods: population-based household surveys and capture-recapture. During the first month of the dry season, the first month of the rainy season, and the last month of the rainy season, respectively, 16.2% [14.7; 17.7], 9.3% [7.2; 11.3], and 5.3% [4.4; 6.1] of the adult population were estimated to have engaged in forest-going activities. The capture-recapture method estimated a total population size of 18,426 [16,529; 20,669] forest-goers, meaning 61.0% [54.2; 67.9] of the adult population had engaged in forest-going activities over the 12-month study period. This study demonstrates two methods for population size estimation to inform malaria research and programming. The seasonality and turnover within this forest-going population provide unique opportunities and challenges for control programs across the GMS as they work towards malaria elimination., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
38. Spatio-temporal associations between deforestation and malaria incidence in Lao PDR.
- Author
-
Rerolle F, Dantzer E, Lover AA, Marshall JM, Hongvanthong B, Sturrock HJ, and Bennett A
- Subjects
- Humans, Incidence, Laos epidemiology, Conservation of Natural Resources, Forests, Malaria, Falciparum epidemiology, Malaria, Vivax epidemiology
- Abstract
As countries in the Greater Mekong Sub-region (GMS) increasingly focus their malaria control and elimination efforts on reducing forest-related transmission, greater understanding of the relationship between deforestation and malaria incidence will be essential for programs to assess and meet their 2030 elimination goals. Leveraging village-level health facility surveillance data and forest cover data in a spatio-temporal modeling framework, we found evidence that deforestation is associated with short-term increases, but long-term decreases confirmed malaria case incidence in Lao People's Democratic Republic (Lao PDR). We identified strong associations with deforestation measured within 30 km of villages but not with deforestation in the near (10 km) and immediate (1 km) vicinity. Results appear driven by deforestation in densely forested areas and were more pronounced for infections with Plasmodium falciparum ( P. falciparum ) than for Plasmodium vivax ( P. vivax ). These findings highlight the influence of forest activities on malaria transmission in the GMS., Competing Interests: FR, ED, AL, JM, BH, HS, AB No competing interests declared, (© 2021, Rerolle et al.)
- Published
- 2021
- Full Text
- View/download PDF
39. Tools to accelerate falciparum malaria elimination in Cambodia: a meeting report.
- Author
-
Lek D, Callery JJ, Nguon C, Debackere M, Sovannaroth S, Tripura R, Wojnarski M, Piola P, Khean ST, Manion K, Nguon S, Kunkel A, Vernaeve L, Peto TJ, Dantzer E, Davoeung C, Etienne W, Dondorp AM, Tuseo L, von Seidlein L, and Guintran JO
- Subjects
- Antimalarials therapeutic use, Cambodia, Humans, Diagnostic Tests, Routine, Disease Eradication instrumentation, Malaria, Falciparum prevention & control, Mass Drug Administration economics, Mass Screening
- Abstract
Cambodia targets malaria elimination by 2025. Rapid elimination will depend on successfully identifying and clearing malaria foci linked to forests. Expanding and maintaining universal access to early diagnosis and effective treatment remains the key to malaria control and ultimately malaria elimination in the Greater Mekong Subregion (GMS) in the foreseeable future. Mass Drug Administration (MDA) holds some promise in the rapid reduction of Plasmodium falciparum infections, but requires considerable investment of resources and time to mobilize the target communities. Furthermore, the most practical drug regimen for MDA in the GMS-three rounds of DHA/piperaquine-has lost some of its efficacy. Mass screening and treatment benefits asymptomatic P. falciparum carriers by clearing chronic infections, but in its current form holds little promise for malaria elimination. Hopes that "highly sensitive" diagnostic tests would provide substantial advances in screen and treat programmes have been shown to be misplaced. To reduce the burden on P. falciparum and Plasmodium vivax infections in people working in forested areas novel approaches to the use of malaria prophylaxis in forest workers should be explored. During an October 2019 workshop in Phnom Penh researchers and policymakers reviewed evidence of acceptability, feasibility and effectiveness of interventions to target malaria foci and interrupt P. falciparum transmission and discussed operational requirements and conditions for programmatic implementation.
- Published
- 2020
- Full Text
- View/download PDF
40. Study protocol for a cluster-randomized split-plot design trial to assess the effectiveness of targeted active malaria case detection among high-risk populations in Southern Lao PDR (the AcME-Lao study).
- Author
-
Lover AA, Dantzer E, Hocini S, Estera R, Rerolle F, Smith JL, Hwang J, Gosling R, Yukich J, Greenhouse B, Jacobson J, Phetsouvanh R, Hongvanthong B, and Bennett A
- Abstract
Introduction: Novel interventions are needed to accelerate malaria elimination, especially in areas where asymptomatic parasitemia is common, and where transmission generally occurs outside of village-based settings. Testing of community members linked to a person with clinical illness (reactive case detection, RACD) has not shown effectiveness in prior studies due to the limited sensitivity of current point-of-care tests. This study aims to assess the effectiveness of active case finding in village-based and forested-based settings using novel high-sensitivity rapid diagnostic tests in Lao People's Democratic Republic (Lao PDR). Methods and analysis: This study is a cluster-randomized split-plot design trial. The interventions include village-based mass test and treat (MTAT), focal test and treat in high-risk populations (FTAT), and the combination of these approaches, using high-sensitivity rapid diagnostic tests (HS-RDTs) to asses P. falciparum infection status. Within four districts in Champasak province, Lao PDR fourteen health center-catchment areas will be randomized to either FTAT or control; and within these HCCAs, 56 villages will be randomized to either MTAT or control. In intervention areas, FTAT will be conducted by community-based peer navigators on a routine basis, and three separate rounds of MTAT are planned. The primary study outcome will be PCR-based Plasmodium falciparum prevalence after one year of implementation. Secondary outcomes include malaria incidence; interventional coverage; operational feasibility and acceptability; and cost and cost- effectiveness. Ethics and dissemination: Findings will be reported on clinicaltrials.gov, in peer-reviewed publications and through stakeholder meetings with Ministry of Health and community leaders in Lao PDR and throughout the Greater Mekong Subregion. Trial registration: clinicaltrials.gov NCT03783299 (21/12/2018)., Competing Interests: No competing interests were disclosed., (Copyright: © 2019 Lover AA et al.)
- Published
- 2019
- Full Text
- View/download PDF
41. Performance of Four Respiratory Rate Counters to Support Community Health Workers to Detect the Symptoms of Pneumonia in Children in Low Resource Settings: A Prospective, Multicentre, Hospital-Based, Single-Blinded, Comparative Trial.
- Author
-
Baker K, Alfvén T, Mucunguzi A, Wharton-Smith A, Dantzer E, Habte T, Matata L, Nanyumba D, Okwir M, Posada M, Sebsibe A, Nicholson J, Marasciulo M, Izadnegahdar R, Petzold M, and Källander K
- Abstract
Background: Pneumonia is one of the leading causes of death in children under-five globally. The current diagnostic criteria for pneumonia are based on increased respiratory rate (RR) or chest in-drawing in children with cough and/or difficulty breathing. Accurately counting RR is difficult for community health workers (CHWs). Current RR counting devices are frequently inadequate or unavailable. This study analysed the performance of improved RR timers for detection of pneumonia symptoms in low-resource settings., Methods: Four RR timers were evaluated on 454 children, aged from 0 to 59 months with cough and/or difficulty breathing, over three months, by CHWs in hospital settings in Cambodia, Ethiopia, South Sudan and Uganda. The devices were the Mark Two ARI timer (MK2 ARI), counting beads with ARI timer, Rrate Android phone and the Respirometer feature phone applications. Performance was evaluated for agreement with an automated RR reference standard (Masimo Root patient monitoring and connectivity platform with ISA CO
2 capnography). This study is registered with ANZCTR [ACTRN12615000348550]., Findings: While most CHWs managed to achieve a RR count with the four devices, the agreement was low for all; the mean difference of RR measurements from the reference standard for the four devices ranged from 0.5 (95% C.I. - 2.2 to 1.2) for the respirometer to 5.5 (95% C.I. 3.2 to 7.8) for Rrate. Performance was consistently lower for young infants (0 to < 2 months) than for older children (2 to ≤ 59 months). Agreement of RR classification into fast and normal breathing was moderate across all four devices, with Cohen's Kappa statistics ranging from 0.41 (SE 0.04) to 0.49 (SE 0.05)., Interpretation: None of the four devices evaluated performed well based on agreement with the reference standard. The ARI timer currently recommended for use by CHWs should only be replaced by more expensive, equally performing, automated RR devices when aspects such as usability and duration of the device significantly improve the patient-provider experience., Funding: Bill & Melinda Gates Foundation [OPP1054367]., Competing Interests: None declared.- Published
- 2019
- Full Text
- View/download PDF
42. Prevalence and risk factors for asymptomatic malaria and genotyping of glucose 6-phosphate (G6PD) deficiencies in a vivax-predominant setting, Lao PDR: implications for sub-national elimination goals.
- Author
-
Lover AA, Dantzer E, Hongvanthong B, Chindavongsa K, Welty S, Reza T, Khim N, Menard D, and Bennett A
- Subjects
- Adolescent, Adult, Aged, Child, Cluster Analysis, Cross-Sectional Studies, Female, Glucosephosphate Dehydrogenase Deficiency genetics, Humans, Laos epidemiology, Malaria parasitology, Male, Middle Aged, Prevalence, Risk Factors, Young Adult, Asymptomatic Infections epidemiology, Communicable Disease Control, Genotype, Glucosephosphate Dehydrogenase Deficiency epidemiology, Malaria epidemiology
- Abstract
Background: Lao People Democratic Republic (PDR; Laos), a landlocked country in Southeast Asia, has made important progress in reducing malaria morbidity and mortality in the past 5-6 years, and the northern provinces have very low reported incidence. To support national progress towards elimination, it is critical to verify and understand these changes in disease burden., Methods: A two-stage cluster cross-sectional survey was conducted in four districts within four northern provinces (Khua, Phongsaly Province; Paktha, Bokeo Province; Nambak, Luang Prabang, and Muang Et, Huaphanh Province). During September and October 2016, demographics and malaria risk factors were collected from a total of 1492 households. A total of 5085 persons consented to collection of blood samples for testing, by rapid diagnostic test (RDT) and polymerase chain reaction (PCR)-based testing. Risk factors for infection were examined using logistic regression; and a randomized subset of males was tested for glucose-6-phosphate dehydrogenase (G6PD) deficiencies using a combined PCR and sequencing approach., Results: There were zero positives by RDT, and PCR detected Plasmodium infections in 39 (0.77%; 95% CI 0.40-1.47%) of 5082 analysable samples. The species distribution was Plasmodium vivax (28 total); Plasmodium falciparum/P. vivax (5); P. falciparum (3), Plasmodium malariae (2), and P. vivax/P. malariae (1). In multivariable analysis, the main risk factors included having any other cases within the household [aOR 12.83 (95% CI 4.40 to 37.38), p < 0.001]; and lack of bed net ownership within the household [aOR 10.91 (95% 5.42-21.94), p < 0.001]; age, sex and forest-travel were not associated with parasitaemia. A total of 910 males were tested for the six most common G6PDd in SE Asia; and 30 (3.3%; 95% CI 2.1-5.1%) had a G6PD variant allele associated with G6PD deficiency, with the majority being the Union (14) and Viangchan (11) polymorphisms, with smaller numbers of Canton and Mahidol., Conclusion: This is the first rigorous PCR-based population survey for malaria infection in Northern Lao PDR, and found a very low prevalence of asymptomatic Plasmodium infections by standard PCR methods, with P. vivax predominating in the surveyed districts. Clustering of cases within households, and lack of a bed nets suggest reactive case detection, and scale-up of coverage should be prioritized. The predominance of infections with P. vivax, combined with moderate levels of serious G6PD deficiencies highlight the need for careful rollout of primaquine towards elimination goals.
- Published
- 2018
- Full Text
- View/download PDF
43. A shortened verbal autopsy instrument for use in routine mortality surveillance systems.
- Author
-
Serina P, Riley I, Stewart A, Flaxman AD, Lozano R, Mooney MD, Luning R, Hernandez B, Black R, Ahuja R, Alam N, Alam SS, Ali SM, Atkinson C, Baqui AH, Chowdhury HR, Dandona L, Dandona R, Dantzer E, Darmstadt GL, Das V, Dhingra U, Dutta A, Fawzi W, Freeman M, Gamage S, Gomez S, Hensman D, James SL, Joshi R, Kalter HD, Kumar A, Kumar V, Lucero M, Mehta S, Neal B, Ohno SL, Phillips D, Pierce K, Prasad R, Praveen D, Premji Z, Ramirez-Villalobos D, Rampatige R, Remolador H, Romero M, Said M, Sanvictores D, Sazawal S, Streatfield PK, Tallo V, Vadhatpour A, Wijesekara N, Murray CJ, and Lopez AD
- Subjects
- Adult, Cause of Death, Child, Preschool, Developing Countries, Humans, Infant, Newborn, Reproducibility of Results, Surveys and Questionnaires, Epidemiological Monitoring
- Abstract
Background: Verbal autopsy (VA) is recognized as the only feasible alternative to comprehensive medical certification of deaths in settings with no or unreliable vital registration systems. However, a barrier to its use by national registration systems has been the amount of time and cost needed for data collection. Therefore, a short VA instrument (VAI) is needed. In this paper we describe a shortened version of the VAI developed for the Population Health Metrics Research Consortium (PHMRC) Gold Standard Verbal Autopsy Validation Study using a systematic approach., Methods: We used data from the PHMRC validation study. Using the Tariff 2.0 method, we first established a rank order of individual questions in the PHMRC VAI according to their importance in predicting causes of death. Second, we reduced the size of the instrument by dropping questions in reverse order of their importance. We assessed the predictive performance of the instrument as questions were removed at the individual level by calculating chance-corrected concordance and at the population level with cause-specific mortality fraction (CSMF) accuracy. Finally, the optimum size of the shortened instrument was determined using a first derivative analysis of the decline in performance as the size of the VA instrument decreased for adults, children, and neonates., Results: The full PHMRC VAI had 183, 127, and 149 questions for adult, child, and neonatal deaths, respectively. The shortened instrument developed had 109, 69, and 67 questions, respectively, representing a decrease in the total number of questions of 40-55%. The shortened instrument, with text, showed non-significant declines in CSMF accuracy from the full instrument with text of 0.4%, 0.0%, and 0.6% for the adult, child, and neonatal modules, respectively., Conclusions: We developed a shortened VAI using a systematic approach, and assessed its performance when administered using hand-held electronic tablets and analyzed using Tariff 2.0. The length of a VA questionnaire was shortened by almost 50% without a significant drop in performance. The shortened VAI developed reduces the burden of time and resources required for data collection and analysis of cause of death data in civil registration systems.
- Published
- 2015
- Full Text
- View/download PDF
44. Improving performance of the Tariff Method for assigning causes of death to verbal autopsies.
- Author
-
Serina P, Riley I, Stewart A, James SL, Flaxman AD, Lozano R, Hernandez B, Mooney MD, Luning R, Black R, Ahuja R, Alam N, Alam SS, Ali SM, Atkinson C, Baqui AH, Chowdhury HR, Dandona L, Dandona R, Dantzer E, Darmstadt GL, Das V, Dhingra U, Dutta A, Fawzi W, Freeman M, Gomez S, Gouda HN, Joshi R, Kalter HD, Kumar A, Kumar V, Lucero M, Maraga S, Mehta S, Neal B, Ohno SL, Phillips D, Pierce K, Prasad R, Praveen D, Premji Z, Ramirez-Villalobos D, Rarau P, Remolador H, Romero M, Said M, Sanvictores D, Sazawal S, Streatfield PK, Tallo V, Vadhatpour A, Vano M, Murray CJ, and Lopez AD
- Subjects
- Female, Humans, Male, Autopsy methods, Cause of Death
- Abstract
Background: Reliable data on the distribution of causes of death (COD) in a population are fundamental to good public health practice. In the absence of comprehensive medical certification of deaths, the only feasible way to collect essential mortality data is verbal autopsy (VA). The Tariff Method was developed by the Population Health Metrics Research Consortium (PHMRC) to ascertain COD from VA information. Given its potential for improving information about COD, there is interest in refining the method. We describe the further development of the Tariff Method., Methods: This study uses data from the PHMRC and the National Health and Medical Research Council (NHMRC) of Australia studies. Gold standard clinical diagnostic criteria for hospital deaths were specified for a target cause list. VAs were collected from families using the PHMRC verbal autopsy instrument including health care experience (HCE). The original Tariff Method (Tariff 1.0) was trained using the validated PHMRC database for which VAs had been collected for deaths with hospital records fulfilling the gold standard criteria (validated VAs). In this study, the performance of Tariff 1.0 was tested using VAs from household surveys (community VAs) collected for the PHMRC and NHMRC studies. We then corrected the model to account for the previous observed biases of the model, and Tariff 2.0 was developed. The performance of Tariff 2.0 was measured at individual and population levels using the validated PHMRC database., Results: For median chance-corrected concordance (CCC) and mean cause-specific mortality fraction (CSMF) accuracy, and for each of three modules with and without HCE, Tariff 2.0 performs significantly better than the Tariff 1.0, especially in children and neonates. Improvement in CSMF accuracy with HCE was 2.5%, 7.4%, and 14.9% for adults, children, and neonates, respectively, and for median CCC with HCE it was 6.0%, 13.5%, and 21.2%, respectively. Similar levels of improvement are seen in analyses without HCE., Conclusions: Tariff 2.0 addresses the main shortcomings of the application of the Tariff Method to analyze data from VAs in community settings. It provides an estimation of COD from VAs with better performance at the individual and population level than the previous version of this method, and it is publicly available for use.
- Published
- 2015
- Full Text
- View/download PDF
45. Tracheal intubation difficulties in the setting of face and neck burns: myth or reality?
- Author
-
Esnault P, Prunet B, Cotte J, Marsaa H, Prat N, Lacroix G, Goutorbe P, Montcriol A, Dantzer E, and Meaudre E
- Subjects
- Adult, Airway Obstruction etiology, Burns complications, Cohort Studies, Facial Injuries complications, Female, Humans, Laryngeal Edema etiology, Linear Models, Male, Middle Aged, Multivariate Analysis, Neck Injuries complications, Odds Ratio, Retrospective Studies, Risk Factors, Severity of Illness Index, Time Factors, Time-to-Treatment, Airway Obstruction therapy, Burn Units statistics & numerical data, Burns therapy, Facial Injuries therapy, Intubation, Intratracheal statistics & numerical data, Neck Injuries therapy, Respiratory Insufficiency therapy
- Abstract
Introduction: Face and/or neck burn (FNB) exposes patients to the double respiratory risk of obstruction and hypoxia, and these risks may require a tracheal intubation. This study aims to describe the incidence and the characteristics of difficult intubation in FNB patients., Methods: We conducted a 5-year retrospective, single-center study including all patients meeting the following criteria: 18 years of age or older, an FNB at least 1% of burned surface area with a severity equal to or greater than the superficial second degree, and intubation and a burn center admission within the first 24 hours after the burn. Patients were compared according to the difficulty of their intubation., Results: Between January 2007 and December 2011, we included 134 patients. The incidence of difficult intubation was 11.2% but was greater in the burn center than in the pre-burn center: 16.9% vs 3.5% (P = .02). The most important difference between patients with or without difficult intubation was the time between the burn injury and the intubation: 210 (105-290) vs 120 (60-180) minutes (P = .047). After multivariate analysis, an intubation performed at a burn center was independently associated with difficult intubation: odds ratio = 3.2; 95% confidence interval, 1.1-528., Conclusions: This study underlines the high incidence of difficult intubation in FNB patients, greater than 11.2%, and demonstrates that intubation is more difficult when realized at a burn center, probably because it is performed later, allowing for development of cervical and laryngeal edema., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
46. Comparison of the Berlin definition with the American European consensus definition for acute respiratory distress syndrome in burn patients.
- Author
-
Bordes J, Lacroix G, Esnault P, Goutorbe P, Cotte J, Dantzer E, and Meaudre E
- Subjects
- Acute Lung Injury etiology, Adult, Aged, Cohort Studies, Female, Humans, Inflammation complications, Male, Middle Aged, Respiration, Artificial, Respiratory Distress Syndrome etiology, Retrospective Studies, Severity of Illness Index, Acute Lung Injury diagnosis, Burns complications, Pneumonia complications, Respiratory Distress Syndrome diagnosis, Smoke Inhalation Injury complications
- Abstract
Objective: Acute respiratory distress syndrome (ARDS) is a leading cause of mortality in burn patients. Smoke inhalation, pneumonia and inflammation process are the major causes of ARDS in burn patients. The American European Consensus Conference (AECC) definition proposed in 1994 has recently been revised by the Berlin definition. Our objective was to describe the epidemiology of ARDS comparing the Berlin definition with the AECC definition in a retrospective cohort of burn patients., Methods: We reviewed admitted burn adult patients for a two year period, and investigated patient who received mechanical ventilation for more than 48 h and in whom pneumonia was diagnosed., Results: 40 patients were analyzed. According to the AECC definition, 11 patients met criteria for ALI (27.5%), and 29 patients for ARDS (72.5%). According to the Berlin definition, all patients met criteria for ARDS: 4 (10%) for a severe ARDS, 25 (62.5%) for a moderate ARDS, 11 (27.5%) for a mild ARDS. Inhalation injury was diagnosed in 10 patients (25%). Categorizing patients with the Berlin definition showed statistically significative difference of mortality within the three groups, but not with the AECC definition., Conclusion: The Berlin definition seems to be more accurate than the AECC definition to assess the severity of ARDS in term of outcome in burn patients. This definition may facilitate prompt recognition of ARDS in burn patients, and promote protective ventilation strategy to a larger number of patients., (Copyright © 2014 Elsevier Ltd and ISBI. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
47. Cytomegalovirus reactivation in critically ill burn patients: it's time to worry about it!
- Author
-
Bordes J, Goutorbe P, Montcriol A, Boret H, Dantzer E, and Meaudre E
- Subjects
- Humans, Male, Cytomegalovirus physiology, Cytomegalovirus Infections virology, Sepsis virology, Virus Activation
- Published
- 2014
- Full Text
- View/download PDF
48. Using verbal autopsy to measure causes of death: the comparative performance of existing methods.
- Author
-
Murray CJ, Lozano R, Flaxman AD, Serina P, Phillips D, Stewart A, James SL, Vahdatpour A, Atkinson C, Freeman MK, Ohno SL, Black R, Ali SM, Baqui AH, Dandona L, Dantzer E, Darmstadt GL, Das V, Dhingra U, Dutta A, Fawzi W, Gómez S, Hernández B, Joshi R, Kalter HD, Kumar A, Kumar V, Lucero M, Mehta S, Neal B, Praveen D, Premji Z, Ramírez-Villalobos D, Remolador H, Riley I, Romero M, Said M, Sanvictores D, Sazawal S, Tallo V, and Lopez AD
- Subjects
- Adult, Autopsy methods, Child, Humans, Infant, Newborn, Internationality, Reproducibility of Results, Autopsy standards, Cause of Death, Physician's Role
- Abstract
Background: Monitoring progress with disease and injury reduction in many populations will require widespread use of verbal autopsy (VA). Multiple methods have been developed for assigning cause of death from a VA but their application is restricted by uncertainty about their reliability., Methods: We investigated the validity of five automated VA methods for assigning cause of death: InterVA-4, Random Forest (RF), Simplified Symptom Pattern (SSP), Tariff method (Tariff), and King-Lu (KL), in addition to physician review of VA forms (PCVA), based on 12,535 cases from diverse populations for which the true cause of death had been reliably established. For adults, children, neonates and stillbirths, performance was assessed separately for individuals using sensitivity, specificity, Kappa, and chance-corrected concordance (CCC) and for populations using cause specific mortality fraction (CSMF) accuracy, with and without additional diagnostic information from prior contact with health services. A total of 500 train-test splits were used to ensure that results are robust to variation in the underlying cause of death distribution., Results: Three automated diagnostic methods, Tariff, SSP, and RF, but not InterVA-4, performed better than physician review in all age groups, study sites, and for the majority of causes of death studied. For adults, CSMF accuracy ranged from 0.764 to 0.770, compared with 0.680 for PCVA and 0.625 for InterVA; CCC varied from 49.2% to 54.1%, compared with 42.2% for PCVA, and 23.8% for InterVA. For children, CSMF accuracy was 0.783 for Tariff, 0.678 for PCVA, and 0.520 for InterVA; CCC was 52.5% for Tariff, 44.5% for PCVA, and 30.3% for InterVA. For neonates, CSMF accuracy was 0.817 for Tariff, 0.719 for PCVA, and 0.629 for InterVA; CCC varied from 47.3% to 50.3% for the three automated methods, 29.3% for PCVA, and 19.4% for InterVA. The method with the highest sensitivity for a specific cause varied by cause., Conclusions: Physician review of verbal autopsy questionnaires is less accurate than automated methods in determining both individual and population causes of death. Overall, Tariff performs as well or better than other methods and should be widely applied in routine mortality surveillance systems with poor cause of death certification practices.
- Published
- 2014
- Full Text
- View/download PDF
49. Early onset pneumonia in patients with severely burned face and neck: a 5-year retrospective study.
- Author
-
Cotte J, Prunet B, Esnault P, Lacroix G, D'aranda E, Cungi PJ, Goutorbe P, Dantzer E, and Meaudre E
- Subjects
- Adult, Aged, Bronchoscopy statistics & numerical data, Female, Humans, Intubation, Intratracheal adverse effects, Intubation, Intratracheal statistics & numerical data, Length of Stay statistics & numerical data, Male, Middle Aged, Respiration, Artificial adverse effects, Respiration, Artificial statistics & numerical data, Retrospective Studies, Risk Factors, Burns complications, Facial Injuries complications, Neck Injuries complications, Pneumonia etiology
- Abstract
Patients with face and neck burns (FNBs) often undergo prehospital intubation, or sustain inhalation injury which are risk factors for pneumonia in specific populations. Early onset pneumonia (EOP) might be caused by initial management. The primary goal of this study was to find risk factors for EOP in FNB patients. This is a retrospective, single-center trial. We screened all FNB patients for EOP with the Clinical Pulmonary Infection Score. Pneumonia diagnosis was with culture from a mini broncho-alveolar lavage. Potential risk factors for EOP were recorded. We included 152 patients, EOP was diagnosed in 58 (38.2%). EOP patients had a greater burned surface area median (20±17% vs. 10±17%; p<0.001), were more frequently intubated during prehospital care (65.5% vs. 21.3%; p<0.001), had more abnormal fiberoptic bronchoscopy at admission (58.6% vs. 19.1%; p=0.002) and a lower initial PaO2/FiO2 ratio (median 314±118.6 vs. 365±105.7; p=0.01). Multivariate analysis showed that only prehospital intubation was independently associated with EOP (odds ratio 3.6; 95% confidence interval, 1.34-10). Prehospital intubation appears to be an independent risk factor for EOP in severe burn patients. Assessments of the risk-benefit ratios of intubating and of not intubating those patients are indicated., (Copyright © 2012 Elsevier Ltd and ISBI. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
50. Barriers and promoters of home-based pasteurization of breastmilk among HIV-infected mothers in greater Dar es Salaam, Tanzania.
- Author
-
Young S, Leshabari S, Arkfeld C, Singler J, Dantzer E, Israel-Ballard K, Mashio C, Maternowska C, and Chantry C
- Subjects
- Adult, Counseling, Decision Making, Female, HIV Infections epidemiology, HIV Infections transmission, Humans, Infant, Infant, Newborn, Mothers education, Pregnancy, Social Support, Surveys and Questionnaires, Tanzania epidemiology, Breast Feeding methods, Communicable Disease Control methods, HIV Infections prevention & control, Infectious Disease Transmission, Vertical prevention & control, Milk, Human, Pasteurization
- Abstract
Background: For the past decade, heat-treating breastmilk has been an infant feeding option recommended by the World Health Organization as a strategy to reduce vertical transmission. However, little is known about field experiences with it. Our primary objective was to explore the barriers and promoters of the implementation of breastmilk pasteurization, "flash-heating" (FH), in the real-world setting of Dar es Salaam, Tanzania., Subjects and Methods: Nineteen in-depth interviews were conducted with participants in a home-based infant feeding counseling intervention in which FH was promoted after 6 months of exclusive breastfeeding. Additionally, three focus group discussions were conducted with peer counselors. Interviews were transcribed, translated, and coded independently using NVivo 8 software (QSR International). Data were analyzed using the socioecological framework., Results: Information and support provided by peer counselors were the most important promoters of initiation and continuation of FH; this impacted individual-, interpersonal-, and institutional-level promoters of success. Other promoters included perceived successful breastmilk expression, infant health after initiation of FH, and the inability to pay for replacement milks. Stigma was the most important barrier and cut across all levels of the framework. Other barriers included doubt about the safety or importance of pasteurized breastmilk, difficulties with expressing milk (often attributed to poor diet), and competing responsibilities. The most common suggestion for improving the uptake and duration of FH was community education., Conclusions: Given the acknowledged role of breastmilk pasteurization in the prevention of vertical transmission, further implementation research is needed. A multilevel intervention addressing barriers to FH would likely improve uptake.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.